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Abstract
When challenged by viral DNA, the cytoplasmic DNA sensor cyclic GMP-AMP synthase
(cGAS) signals through the adaptor protein stimulator of interferon genes (STING) to
induce a primary type I IFN response. Studies from recent years have also revealed shared
architecture between metabolism and innate immunity. Viruses have evolved to counteract
these mechanisms. Human adenovirus (HAdV) early region 1A (E1A) protein antagonizes
the cGAS-STING pathway to prevent an innate immune response by physically interacting
with STING. I hypothesize that the interaction between E1A and STING is mediated
through several motifs and involves ribosomal protein S6 kinase beta-1 (S6K1). Using a
series of co-immunoprecipitation assays, I determined that the interaction between STING
and HAdV E1A is conserved and mediated through the E1A N-terminus region. I also
found that E1A physically interacts with S6K1 and ribosomal protein S6 (RPS6). Further
studies will reveal the biological function of these interactions.
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Chapter 1
1.1 Innate Immune Recognition of Pathogens and Trauma:
PAMPs, MAMPs, and DAMPs
Innate immunity is acknowledged as the first line of defense against invading foreign
microbes and operates as a quick and sensitive counterattack mechanism. As response time
post-exposure to an infectious agent can be absolutely paramount, sensors to detect
incoming foreign microbial matter are strategically located within the cell. These sensors
contain germline-encoded receptors called innate pattern recognition receptors (PRRs), and
research over the past decade has shown that these PRRs have extensive breadth in host
cell range and ligand specificity (Yoneyama et al., 2004; Kawai & Akira, 2011). Triggering
of PRRs subsequently leads to intracellular signalling cascades that ultimately result in the
transcriptional expression of inflammatory mediators that eliminate infected cells and
pathogens (Takeuchi & Akira, 2010).
Pathogen-associated molecular patterns (PAMPs) and microbe-associated molecular
patterns (MAMPs) are conserved molecular structures found in microbial pathogens, such
as flagellins, peptidoglycans, and lipopolysaccharides (Wu & Chen, 2014). However,
nucleic acids can also act as PAMPs/MAMPs because DNA is an essential genetic material
across all organisms (with the exception of RNA viruses). Nucleic acids themselves are
not regarded as the ‘problem’, but rather the mislocalization of nucleic acids in the
cytoplasm triggers specific PRRs, and detection of anomalous nucleic acids serves as a
fundamental mechanism of host defense. Nucleic acids can also act as damage-associated
molecular patterns (DAMPs), which are biomolecules derived from the host that trigger
innate immunity in response to trauma, cellular stress, tissue damage, and necrotic cell
death (Tang et al., 2013).
However, there exists no perfect biological system, and the detection of DNA, particularly
double-stranded DNA, by innate immune sensors can lead to autoimmune diseases such as
Aicardi-Goutieres Syndrome (AGS) and Systemic Lupus Erythematosus (SLE)(Ablasser
et al., 2013). Therefore, the host has evolved a range of distinct PRRs to identify different
PAMPs and activate appropriate and specific cellular responses to combat infection
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(Yoneyama et al., 2005; Ablasser et al., 2013). The innate immune sensors involved in
sensing nucleic acids can be subdivided into multiple groups depending on where they are
located within the cell, the cell type, and their targets of recognition (Kawai & Akira, 2011).
To date, the Toll-like receptor (TLR) family is the most extensively studied of these groups
and has provided new insights into the mechanisms by which PRRs operate.

1.2

Toll-like Receptors

Toll-like receptors are often cited as the prototypical PRRs that recognize PAMPs or
damage-associated molecular patterns (DAMPs). These single transmembrane proteins
contain leucine-rich domains designed to recognize PAMPs. Structurally, TLRs also
contain a transmembrane domain, situated upstream of the cytosolic Toll/IL-1 receptor
(TIR) domain, which is highly effective at transducing signals to the downstream adaptor
proteins TIR-domain-containing adapter-inducing interferon-β (TRIF) and myeloid
differentiation primary response gene 88 (MyD88)(Figure 1.1)(Bell et al., 2003; Bell et al.,
2005; Ishii et al., 2005; Kawai & Akira, 2010). TLRs undergo dimerization, which is
initiated by the binding of extracellular ligands. This triggers the interaction of the TIR
domain with adapter molecules to initiate downstream signaling. The adaptor proteins
TRIF and MyD88 both activate nuclear factor-ĸB (NF-ĸB), but the MyD88 pathway results
in the activation of interferon regulatory factor 7 (IRF7), while the TRIF pathway leads to
the activation of interferon regulatory factor 3 (IRF3)(Xu et al., 2000; Tao et al., 2002
Khan et al., 2004; Kawai & Akira, 2010). These IRFs are integral members of the
interferon regulatory factor family of transcription factors. Activated IRF3 and IRF7
translocate to the nucleus and play a role in transcriptional activation of type I interferon
(IFN) genes. IRF3 induces interferon-beta (IFN-β) expression, while IRF7 induces IFN-β
and interferon-alpha (IFN-α) expression to activate innate immune cell responses
(Colonna, 2007). The type I IFN response is described in detail in section 1.6.
The genetic family of TLRs has expanded relatively quickly over the last decade. To date,
five (of ten) TLRs in humans have been characterized for their ability to recognize nucleic
acids, and these include: TLR3, TLR4, TLR7, TLR8 and TLR9 (O’Neill et al., 2013; Tao
et al., 2016). Several groups took it upon themselves to identify the ligand specificities of
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Figure 1.1 Signaling pathways of the toll-like receptors (TLRs)s, RIG-like
receptors (RLRs), and DNA sensors. Diagram depicting a general outline of the three
most studied PRRs and their signaling pathways. TLRs are found within endosomal
compartments and anchored to the cell surface membrane. TLRs activate the
downstream adaptor proteins MyD88 or TRIF, which recruit downstream molecules to
trigger the secretion of pro-inflammatory cytokines and type I IFN. RLRs RIG-1 and
MDA5 activate and recruit the adaptor protein MAVS to trigger NF-κB and type I IFN.
The cytoplasmic DNA sensor cGAS binds DNA and triggers the formation of a second
messenger (cGAMP) (not shown) to activate STING, which in turn traffics from the ER
and recruits TBK1 and IRF3, leading to the secretion of type I IFN. Dashed arrow
represents signaling between STING and RIG-1 (Wu et al., 2017). Adapted from Ma &
Damania, 2016.
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nucleic acid-sensing TLRs. Both synthetically generated ligands together with pathogenderived nucleic acids, such as genetic viral fragments, were used to challenge TLRs. For
example, TLR3 was determined to be a double-stranded RNA (dsRNA) sensor using the
synthetic analog polyinosinic-polycytidylic acid (Marshall-Clarke et al., 2007), and then
subsequently shown to restrict several RNA viruses, including West Nile Virus, and
Respiratory Syncytial Virus (Negishi et al., 2008; Wu & Chen, 2014). It was also
discovered that TLR3 could recognize a select number of dsRNA replicative intermediates
from various single-stranded (ssRNA) viruses (Bell et al., 2006).
With the exception of TLR3 and TLR4, many TLRs are expressed on the cell surface.
TLR3 and 4 are located within the endoplasmic reticulum, endosomes, and endolysosome.
TLR7 recognizes ssRNA sequences rich in guanosine and uridine, and thus operates to
restrict Influenza A Virus, Vesicular Stomatitis Virus (VSV) and Sendai Virus.
Additionally, TLR7 and the functionally similar TLR8 have gained attention for their
recognition of Human Immunodeficiency Virus (HIV) (Diebold et al., 2004; Heil et al.,
2004; Hofmann et al., 2016).
The notable discovery of the first DNA sensor TLR9 was made in the year 2000 by Hemmi
and colleagues. TLR9 is located within the endosomal lumen and monitors for microbial
unmethylated cytosine-phosphate-guanine (CpG) dinucleotides (Krieg, 2004). Monitoring
for unmethylated CpG DNA allows for the vital distinction between host and foreign DNA,
as host genomes generally have methylated cytosines at CpG sites. Up to 90% of the
vertebrate genomic CpGs are believed to be in a methylated state (Kass et al., 1997; Ng &
Bird, 1999; Hoelzer et al., 2008). The evolutionary pressures placed upon host cells from
microbes drives innate immunity into a diversification of the levels of nucleic acid-sensing
TLRs. Many of the TLRs are structured such that their ligand binding domains face inwards
toward the endosomal lumen of immune cells. This effectively prevents them from
detecting any incoming pathogens traveling through the cytoplasm. The role of TLRs, or
lack thereof, in innate immunity was questioned with the observation that several different
nonimmune cells, such as fibroblasts, do not have TLRs yet are capable of mounting innate
immune responses to infection (O’Neill et al., 2013). This led to the subsequent discovery
of pathways involved in cytoplasmic nucleic acid sensing (Wu & Chen, 2014).
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1.3

Cytoplasmic Sensing of Nucleic Acids

As a foreward to the topic of cytoplasmic sensing of nucleic acids, it should be mentioned
that pre-2017, researchers categorized cytoplasmic sensing pathways into two main
families, each characterized by their mode of ligand recognition; DNA or RNA. However,
new research is beginning to reveal signaling events between cytoplasmic sensors and
downstream adaptor proteins across these families, thus categorizing whole pathways
under groups of strictly DNA-detecting or RNA-detecting would appear too general.
Therefore, the following summary of cytoplasmic sensing pathways should be viewed,
keeping in mind, that some studies will be reanalyzed to accommodate these new insights.
Viral RNA (vRNA) is a very strong TLR-independent activator of type I IFNs (Diebold et
al., 2003) and detection within the cytoplasm of vRNA occurs through RIG-1-like
receptors (RLRs)(Yoneyma et al., 2004). The first RLR to be described was the
cytoplasmic sensor retinoic acid-inducible gene 1 (RIG-1), which was required for dsRNAinduced IFN induction. The second most notable RLR is the cytoplasmic RNA sensor
melanoma differentiation associated gene 5 (MDA5) (Figure 1.1)(Yoneyama et al., 2005;
Kolakofsky et al., 2012). Sensors that constitute an RLR have a highly conserved domain
structure; a DExD/H-box helicase core composed of two helicase domains. The C-terminal
domain of RLRs is the area where ligand specificity has evolved (Kolakofsky et al., 2012;
Luo et al., 2013). MDA5 and RIG-1 also have two caspase activation and recruitment
domains (CARDs), which mediate the downstream signaling to adaptor protein
mitochondrial antiviral-signaling pathway (MAVS)(Figure 1.1)(Jiang et al., 2012;
Kowalinski et al., 2011). The ligand specificities between RIG-1 and MDA5 are dissimilar,
with the length of the RNA being the critical distinction factor. MDA5 recognizes long
synthetic RNA fragments (>3.9Kb), while RIG-I is activated by shorter synthetic RNA
fragments (∼300bp) (Kato et al., 2008). The structure of the RNA cap is also used by RIG1 as a method of detecting vRNA. Pathogenic RNA carries a 5’-triphosphate (5’ppp) group
(Hornung et al., 2006; Pichlmair et al., 2006) while eukaryotic mRNA evades RIG-1
detection because of post-translational modifications that result in 5’-end capping with 7methyl guanosine (m7G0) and 2’-O-methylation of 5’-end nucleotides (Devarkar et al.,
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2016). RNA derived from viruses can either be recognized by MDA5 or RIG-1, or both.
Detection of RNA by MDA5 sensors is less understood compared to RIG-1, but one study
demonstrated that high molecular weight RNA can form web-like structures because of an
inclusion of both ssRNA and dsRNA, and this induces IFN activity in a MDA5-dependent
manner (Pichlmair et al., 2009). Looking further downstream at the adaptor protein MAVS,
Sun and colleagues (2006) demonstrated through mouse knockout studies that viral
induction of type I IFN was abolished in MAVS -/- mice, leaving the mice highly
susceptible to lethal Vesicular Stomatitis Virus infection. The induction of type I IFNs and
cytokines by MDA5/RLRs and MAVS also acts through two cytosolic kinases, IκB kinase
(IKK) and tank-binding kinase 1 (TBK1), which activate IRF3 and IRF7 via
phosphorylation (Seth et al., 2005).
Intriguingly, Ishii and colleagues (2006) discovered that B-form double-stranded DNA
poly(dA:dT) could activate type I IFNs in a RIG-I/MAVS dependent manner in certain cell
types. There was much confusion over this phenomenon, but that was subsequently
diminished when two independent studies were conducted demonstrating that poly(dA:dT)
could be converted to RNA that bore a 5’triphosphate group and had double-stranded
secondary structures, much like the ligands for RIG-1. DNA-dependent RNA Polymerase
III (Pol-III) was the enzyme responsible for synthesizing 5’triphosphate RNA from the
poly(dA:dT) template (Ablasser et al., 2009; Chiu et al., 2009). The plasticity of Pol-III
acting as a DNA sensor allows the RIG-1/MAVS pathway to defend against pathogens by
an alternative mechanism. However, the strict dependence that Pol-III has for AT-rich
sequence, and the fact that Type I IFN production could occur through sequenceindependent mechanisms hinted that another DNA-sensing pathway was yet to be found
(Wu & Chen, 2014).

1.4

The cGAS-STING Pathway

In 1908, Mechnikov spoke of the immunostimulatory abilities of nucleic acids, long before
the structure of DNA was established in 1953 (Mechnikov, 1908). The main cytosolic DNA
sensor that could lead to such a robust type I IFN response remained elusive until 2012,
when the breakthrough by Dr. Zhijian Chen’s group led to the identification of cyclic GMP-
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AMP synthase (cGAS) using quantitative mass spectrometry and biochemical fractionation
(Sun et al., 2013). cGAS is a nucleotidyl transferase (NTase) and as such, possesses the
structurally conserved NTase core domain. cGAS provides surveillance within the
cytoplasm and upon recognizing and binding target sequence-independent DNA, cGAS
catalyzes the synthesis of the cyclic dinucleotide (CDN) cyclic GMP-AMP (cGAMP) from
ATP and GTP (Sun et al., 2013; Wu et al., 2013). Extensive work by multiple groups went
into describing the phosphodiester linkages between GMP and AMP, predominantly to
show that a mix of phosphodiester products could be produced. Both an endogenous
mammalian form and bacterial form of cGAMP have been structurally analyzed. The
metazoan 2’3’-cGAMP and bacterial second messengers c-di-GMP, c-di-AMP, and 3’3’cGAMP can all bind and activate the adaptor molecule stimulator of interferon genes
(STING), triggering innate immune defense (Gao et al., 2013). The secretory mechanisms
of these CDNs continues to be studied (Civril et al., 2013; Zhang et al., 2013; Ablasser et
al., 2013; Diner et al., 2013).
STING (also known as MITA, MPYS, ERIS and TMEM173) was discovered between
2008 and 2009 by four independent groups through the use of cDNA expression library
screens (Jin et al., 2008; Zhong et al., 2008; Ishikawa et al., 2009; Sun et al., 2009). STING
is a direct sensor of CDNs and has a broad tissue distribution (Zhong et al., 2008). STING
is anchored to the endoplasmic reticulum through its N-terminal domain, and is comprised
of four transmembrane domains (Ishikawa et al., 2008). The use of crystallography has
also revealed that the carboxyl-terminal domain of STING extends into the cytosol. The
native, unliganded state of STING is a symmetrical dimer in which two monomers of the
C-terminal domain form a cleft. This cleft is the binding site of cGAMP, and each STING
dimer can bind one cGAMP (Shang et al., 2012; Ouyang et al., 2012). Dimerized STING
binds cGAMP (Figure 1.2) which triggers relocalization of STING from the ER to the
Golgi complex (Ishikawa et al., 2009; Shang et al., 2012). STING is phosphorylated by
TBK1 at Serine 366, while the carboxyl-terminal region of STING activates TBK1, which
in turn stimulates the phosphorylation of IRF3 (Tanaka & Chen, 2012). STING is often
described as a ‘scaffold protein’ because of its interaction with both TBK1 and IRF3 to
promote phosphorylation of IRF3. The study by Tanaka and Chen (2012) demonstrated
that selective mutations in STING that disrupted its binding to IRF3 abolished
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Figure 1.2 Structure of human STING in complex with c-di-GMP. (A) Schematic
representation of human STING where black and yellow boxes represent the
transmembrane domain and cytoplasmic C-terminal domain, respectively. Disordered
regions are represented with dashed lines. (B) Ribbon diagram of STING C-terminal
domain in complex with c-di-GMP. Monomer A is yellow and monomer B is purple.
The c-di-GMP is in stick representation. Taken from Shang et al., 2016. Image
reproduced with permission of the rights holder, Nature.
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phosphorylation of IRF3 without impacting activation of TBK1. Phosphorylated IRF3
translocates to the nucleus to induce the transcription of IFN genes (Figure 1.3). Signal
transducer and activator of transcription 6 (STAT6) has also been similarly identified as
being recruited by STING for subsequent phosphorylation by TBK1 and translocation to
the nucleus. This leads to the induction of genes responsible for immune cell homing,
namely expression of the STAT6-dependant chemokines CCL2, CCL20, and CCL26
(Chen et al., 2011).
Optimal signaling of STING can enhance the antiviral response, but chronic activation of
STING leads to an excessive and harmful type I IFN and pro-inflammatory cytokine
response. Therefore, STING undergoes several different post-translational modifications
for optimal signaling, including ubiquitination, phosphorylation, sumoylation and
proteasome-mediated degradation. The ubiquitin ligase tripartite motif-containing protein
56 (TRIM56) was demonstrated to bind STING and mediate ubiquitination of STING at
lysine 150, which can facilitate STING dimerization and binding to TBK1 (Tsuchida et al.,
2010). The TRIM32 ubiquitin ligase was also shown to interact with STING and is
important for STING-TBKI interaction upon Sendai Virus and Herpes Simplex Virus 1
infection (HSV-1) (Zhang et al., 2012). STING can also be negatively regulated through
several mechanisms. Recently, a study by Hu and colleagues (2016) revealed how STING
can be stabilized by sumoylation and the SUMO protease SENP2 can mediate degradation
of STING after desumoylation. Ubiquitin ligase ring finger protein 5 (RNF5)-mediated
lysine 48-linked ubiquitination can also control degradation of STING (Zhong et al., 2009).
Within human diploid cells, a negative feedback system has been put in place to avoid
excessive STING response whereby RIG-1 and IL-6 promote STING degradation by
activating/dephosphorylating UNC-51-like kinase (ULK1). Interestingly, this negative
feedback mechanism is not present in HEK293 cells (Wu et al., 2017).

1.5

Viral Evasion of the cGAS-STING Pathway

The Red Queen Hypothesis (L.M. Van Valen, 1973) proposes that organisms must
constantly evolve to survive against evolving opposing organisms. Viruses have adapted
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Figure 1.3 The cGAS-STING DNA sensing pathway. The DNA sensor cGAS binds
DNA and catalyzes the formation of the second messenger 2’3’- cGAMP. 2’3’- cGAMP
binds to the ER bound adaptor protein STING and activates IKK and TBK1. STING
and IRF3 are phosphorylated by TBK1 to form a STING-TBK1-IRF3 complex.
Phosphorylated IRF3 dimerizes and enters the nucleus, where it functions with NF-kB
to induce the expression of type I IFN and pro-inflammatory cytokines (Adapted from
Chen et al., 2016).
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many different methods of evading detection within the cytoplasm through antagonizing
the cGAS-STING DNA sensing pathway. Being the first DNA virus reported to activate
STING in vivo and in vitro, human HSV-1 is widely used in experimental systems as a
viral activator of the cGAS-STING pathway. In one study, knockout of STING in mice
resulted in lethal susceptibility to HSV-1 infection (Kalamvoki & Roizman, 2014).
However, it should be noted that Kalamvoki & Roizman (2014) reported that STING, while
critical for cellular restriction of HSV-1, could also be necessary for HSV-1 replication in
certain cell types.
Continuing with the Herpes Viral family, Kaposi’s Sarcoma-Associated Herpesvirus
(KSHV) can also activate the cGAS-STING pathway. The KSHV viral interferon
regulatory factor 1 (vIRF1) inhibits cGAS-STING dependent IFN-β induction by
preventing STING from binding TBK1, disallowing phosphorylation of STING (Ma et al.,
2015). ORF52, an abundant KSHV tegument protein, was also shown to directly inhibit
cGAS enzymatic activity through a mechanism involving both cGAS binding and DNA
binding. A conserved mechanism is likely at play as the ORF52 homologs in related
Herpesviruses also demonstrate this inhibitory effect (Wu et al., 2015). Finally, the Nterminally truncated cytoplasmic isoforms of KSHV latency associated nuclear antigen
(LANA) can antagonize the cGAS-STING sensing pathway through direct binding with
cGAS, effectively allowing reactivation of latent KSHV (Zhang et al., 2016).
Within the family Hepadnaviridae, Hepatitis B Virus polymerase inhibits STING-triggered
IFN-β promoter activation and can bind STING to attenuate lysine 63-linked
polyubiquitination and functional activation, without modulating STING protein levels.
The RNase H domain is believed to be the interacting partner that effectively suppresses
STING (Liu et al., 2015).
Initial studies involving human Adenovirus by Falck-Pedersen’s group (2014) concluded
that the cGAS/STING pathway was vital for type I IFN induction in response to
Adenovirus. In addition, they did not find evidence of suppression of cGAS/STINGdependent TBK1/IRF3 activation, at least up to 6 hours post-infection. However, these
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experiments were undertaken with recombinant Adenoviruses that omitted the Adenoviral
early genes (i.e. E1A) that regulate antiviral strategies. Lau and colleagues (2015)
investigated previous observations that most immortalized and tumor cell lines (e.g.
HEK293, HeLa, HEK293T) fail to respond to intracellular DNA, whereas primary cell
lines mount a vigorous DNA-activated antiviral response through activation of type I IFN.
Their study tested for type I IFN presence in HEK293 and HeLa cells after transfection
with DNA. Compared to primary human fibroblasts, HEK293 and HeLa cells did not
mount robust responses to transfected DNA. An understanding of how these cells were
immortalized by viral oncogenes (HEK293 cells with the human Adenovirus type 5 E1A
oncogene, and HeLa cells derived from a cervical tumor and positive for HPV18) led to
the hypothesis that a common Leu-X-Cys-X-Glu protein motif sequence present within
E1A and HPV18 E7 may be the point of interaction with STING. Other studies looking at
Adenovirus and IFN production include one by Look and colleagues in 1998, which
reported that E1A blocked STAT1 activation after IFN-β was produced (Look et al., 1998;
Ma & Damania, 2017). Collectively, these studies on Adenovirus suggest that upstream
cGAS/STING-dependent signaling may not affect Adenoviral replication while E1A is
expressed, but further study is required.
The question of whether STING is sufficient to act as a direct sensor for DNA has been
debated within the literature. While the C-terminal domain of STING can independently
associate with dsDNA, it occurs at a significantly lower binding affinity to that of cGAS
(Kd of 200 µM vs. Kd of 88 nM)(Abe et al., 2013). Zhang and colleagues (2014)
demonstrated that adding STING back into HEK293T cells, which do not express
endogenous STING or cGAS, could restore an IFN-β response to cyclic di-nucleotides.
However, this IFN-β response could not be restored upon challenge with dsDNA. As
mentioned earlier, HEK293 cells are also unable to produce a type I IFN response when
challenged with DNA, despite the presence of endogenous STING. When Lau and
colleagues (2015) put cGAMP (5 µM) into HEK293 cells to stimulate STING, they could
not induce a type I IFN response. However, when Zhang and colleagues (2014) put
cGAMP into HEK293 cells to stimulate STING, they reported an almost 30-fold increase
in IFN-β mRNA response. They also reported a very low increase in endogenous IFN-β
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expression in response to immunostimulatory DNA. This puts forward the question of
whether STING expression alone, can stimulate a biologically relevant IFN-β response in
HEK293 cells.

1.6

Type I IFN Signaling

The secretion of type I IFNs is a pivotal antiviral mechanism found in almost all cells that
operates to restrict viral growth and spread. The type I IFN family encodes multiple IFNα gene products and a single IFN-β gene. Generally, type I IFN responses are divided into
two mechanisms, a primary response where the host cell can activate IFN gene expression,
and a secondary response whereby IFN from the primary response binds to type I IFN
(IFNARs) receptors on neighboring cells, leading to the activation and expression of
hundreds of interferon stimulatory genes (ISGs) that ultimately promote further production
of IFN- β and IFN-α (McNab et al,. 2015).
Cells that express TLRs or have intracellular nucleic acid sensing pathways can initiate the
primary type I IFN response. Through TLR signaling, TLRs engage with the adaptor
proteins previously mentioned, TRIF and MyD88, which recruit the kinases TBK1 and
IKK for IRF3 activation and translocation to the nucleus for transcription of IFN- β or –α
genes. Some TLR-adaptor protein complexes recruit the IL-1R-associated kinases (IRAKs)
and TNF receptor-associated factors (TRAFS) to interact with IKKα and activate IRF7
(Liu et al., 2015).
Both the adaptor proteins STING and MAVS have a conserved C-terminal pLxIS (phydrophilic residue, S- phosphorylation site) motif. The phosphorylation of this site occurs
at the time of ligand binding and a mutation within this motif abolishes recruitment of
IRF3. After STING and MAVS are activated by the adaptor proteins TBK1 and TBK1/IKK
respectively, a conserved positively-charged patch on the IRF3 molecule binds STING and
MAVS. This triggers recruitment of a second IRF3 molecule, which upon phosphorylation,
binds with the first monomer to form a dimer. The activated IRF3 dimer translocates to the
nucleus to induce expression of IFN- β or –α (Liu et al., 2015; Lau et al., 2015; McNab et
al. 2015).
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1.7

Metabolism and Immune Regulators

The intricate relationship between metabolism and immune regulators is gradually being
elucidated. This is generating much interest, as the innate immune regulation of metabolic
pathways remains poorly understood because the systemic inflammation seen in chronic
diseases can often overshadow direct underlying molecular causes. Recently, Hasan et al.
(2016) established TBK1-mTORC1 (mechanistic target of rapamycin complex 1) as a key
regulatory axis between cell-intrinsic immune signaling and metabolism. mTORC1 is one
of two distinct complexes formed by the interaction of several proteins with mTOR. mTOR
is a serine/threonine protein kinase and a member of the phosphoionsitide 3-kinase (PI3K)related kinase family. The mTORC1 pathway controls major processes such as autophagy
and lipid and protein synthesis by responding to inputs from cellular cues such as stress,
growth factors, amino acids, and oxygen (Laplante & Sabatini, 2012). Hasan et al. (2016)
put forward the concept that chronic TBK1-STING activation and trafficking can lead not
only to the recruitment of TBK1 and IRF3 signaling, but also bring TBK1 within close
proximity to mTORC1 on the lysosomes. TBK1 was found to suppress mTORC1, leading
to the dysregulation of cellular metabolism.
Wang et al. (2016) later demonstrated that the mTORC1 substrate S6K is recruited to the
STING-TBK1-IRF3 complex to promote IFN signaling during DNA stimulation. The two
forms of ribosomal protein S6 kinase (S6K), S6K1 and S6K2, are effector serine-threonine
kinases downstream of mTOR (Wang et al., 2016). To characterize the profile of
adenovirus-induced IRF3 phosphorylation in mouse bone marrow– derived dendritic cells
(BMDCs), they transduced wild-type BMDCs with recombinant human adenovirus
serotype 5 (rHAdV-5) vector carrying deletions of E1 and E3, which are involved in
mediating adenovirus replication and host immunomodulation. They determined that
S6Ks, especially S6K1, were required for rHAdV-induced activation of IRF3. The
phosphorylation of IRF3 was profoundly impaired in S6K1-/-S6K2-/- BMDCs.
Immunoblotting analysis showed that recombinant rHAdV promoted translocation of IRF3
to the nucleus in wild-type BMDCs but not in S6K1-/- S6K2-/- BMDCs. As previously
discussed, STING has a scaffold function and binds both TBK1 and IRF3, but the binding
of IRF3 to STING was abolished in S6K1-/- S6K2-/- BMDCs. Finally, through a series of

18
co-immunoprecipitation experiments, Wang and colleagues demonstrated that S6K binds
STING to promote IRF3 phosphorylation.

1.8 Human Adenoviruses
The work in this thesis investigates the interplay between human Adenovirus and the
STING pathway. As such, I will briefly introduce human Adenoviruses, which are well
characterized genera in the Adenovirus family of DNA viruses. Infection by Adenoviruses
affects human populations worldwide. While many infections present as asymptomatic,
these viruses are able to infect multiple organ systems, generally causing mild self-limiting
illnesses including gastroenteritis, conjunctivitis, and pharyngitis. However, for children
and immunocompromised individuals, infection can lead to more serious complications
(Krilov, 2005; Walls et al., 2003).
The type and severity of disease can also be dependent on the infectious Adenoviral
species, with Adenovirus F and G generally causing gastroenteritis, whereas Adenovirus
D can cause conjunctivitis (Table.1.1) (Chang et al., 2008; Sambursky et al., 2007; Walls
et al., 2003). A select number of Adenoviruses can be linked with specific historical
outbreaks. For example, Adenovirus 14 is considered responsible for a fatal pneumonia
outbreak in the United States of America in 2005 (Lewis et al., 2009).
Adenoviruses are used to study cell cycle control, DNA replication, transcription mRNA
processing, apoptosis and immunological responses. Identified in 1953, they are small nonenveloped viruses with a linear double-stranded DNA genome of approximately 35 kbp.
There are 100 members within the Adenovirus family, which infect a wide range of species
covering reptiles, avian, and mammals. There are currently 57 members of human
Adenovirus, which are separated into 7 species categorized A through G and characterized
by their biological properties (Table 1.1)(Jones et al., 2007; Walsh et al., 2011). They are
labelled as oncogenic viruses, but do not actually cause cancer in humans (Mackey et al.,
1976; Green et al., 1980). In 1962, human Adenovirus 12 was found to cause tumours in
baby hamsters, which was the first example of a human virus inducing cancers. However,
not all Adenoviruses cause tumours in rodents, but within tissue culture, they can transform
rodent cells. The differences in tumourgenicity can be traced to immune response strategies
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(Trentin et al., 1962; Gallimore, 1972).
Human Adenovirus 5 (HAdV-5) interacts with the host coxsackie-adenovirus receptor
(CAR)(Bewley et al., 1999). The virions enter the cell through receptor-mediated
endocytosis, and are released into the cytoplasm via acidification of the endosome
(Wickham et al., 1993). The genome undergoes uncoating and travels to the nucleus via
the cellular microtubule network. Upon reaching the nucleus, the first gene transcribed is
the early region 1A gene (E1A). E1A performs many functions in the infected cell,
including the rapid induction of transcription of the other early genes: E1B, E2, E3 and E4
(Fessler & Young, 1998; Tollefson et al., 2007). In addition to its role as a potent viral
transactivator, the E1A protein abolishes the activity of the retinoblastoma protein (pRB)
and its family members p107 and p130, which repress the E2F family of transcription
factors. Cell cycle control and progression from the G1 to S phase is largely controlled by
the E2F family (Berk, 1986; DeCaprio, 2009). Abolishing the control of E2F through the
interaction of E1A with pRB promotes cell cycle progression, a well known trait of E1A
function. It is hypothesized that the activation of cell cycle progression in the infected cell
increases the availability of substrates for efficient viral progeny production (Pelka et al.,
2008). E1A also functions to modulate innate immunity, which is described in detail in
section 1.9.

1.9

E1A as a Molecular Hub Protein

The E1A oncoprotein is a classic example of an intrinsically disordered protein that can
operate as a molecular hub (Pelka et al., 2008). E1A displays nuclear and
nucleocytoplasmic localization and can interact with a large number of different cellular
proteins to regulate a wide range of biological processes, including the transcription of viral
and cellular genes, cell cycle, apoptosis, differentiation, transformation, and immune
responses (Figure 1.4). E1A is differentially spliced to produce five isoforms, which have
mRNA sedimentation rates of 13S, 12S, 11S, 10S, and 9S. The two largest of these
products are 13S and 12S, which encode proteins of 289 and 243 amino acids in length,
respectively (Perricaudet et al., 1979; Stephens & Harlow, 1987). Comparing the largest
sequences of E1A proteins across species identifies four highly conserved regions, referred
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Table 1.1 Biological properties of the seven human adenovirus species. Human
Adenovirus species A through G, their hemagglutination group, serotypes, tumorigenicity
in animals, transformation is tissue culture, sequence GC percentage, and linked clinical
infection/disease. Adapted from Berk (2007), Ghebremedhin (2014), and Jones et al.,
(2007).
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Figure 1.4 E1A is a molecular hub protein. Graphic demonstrating the primary and
secondary interactors of E1A. Modeled with the Gephi 0.9.1 software with data from
BioGRID build 3.4.144. E1A is shown as the center molecule, with the primary
interactors represented in the larger coloured circles. Relative sizes are correlated with
number of binding partners. The secondary interactors are represented by the smaller
coloured circles. This diagram represents 31 primary interactors and 2125 unique
secondary interactors. Created by and reproduced with permission from Dr. Joe
Mymryk (Western University, unpublished, 2017).
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to as CR1, CR2, CR3 and CR4 (Figure 1.5). These would indicate regions that are essential
for adenoviral E1A function (Avvakumov et al., 2002). The N-terminus of E1A of most
adenovirus types is predicted to form an α-helix, while the CR regions 1, 2 and 4 are
intrinsically disordered. This allows E1A to form numerous interactions with cellular
proteins through short linear interaction motifs (SLIMs). E1A mediates its effects on
cellular processes through protein-protein interactions, as E1A does not directly bind DNA
and has no enzymatic activity (Ferguson et al., 1985). SLIMs can be 3 to 10 residues is
length and are typically found within intrinsically disordered regions of a protein, but also
can be found on surfaces of solvent-exposed alpha helices. Interactions that are of low
affinity or transient, are mediated by SLIMs, so stable binding between some proteinprotein interactions requires multiple SLIMs mediating the interaction (Davey et al., 2001;
Pelka et al., 2013; Van Roey et al., 2014). There exist a number of HAdV-5 E1A SLIMs
found in the CR2 region, within close proximity to each other (Figure 1.6). The LxCxE
motif within CR2 is used to interact with pRB, in addition to being recently proposed to
interact with STING (Dyson et al., 1992; Fattaey et al., 1993; Lau et al., 2015). The
neighboring PxLxP and EVIDLT motifs are used to interact with BS69 and small ubiquitinlike moiety (SUMO) conjugase ubiquitin conjugase 9 (UBC9), respectively (Ansieau &
Leutz, 2002; Avvakumov et al., 2004; Lau et al., 2015; Yousef et al., 2010). The potential
ability of E1A to interact with multiple partners suggests that, in addition to its ability to
sequester or re-localize individual targets, it may perform a “scaffold” like function to bring
various targets into virally-mediated protein complexes not present in uninfected cells.
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MRHLRDLPDEEIIIASGSEILELVVNATM-GDDHPEPP-TPFGTPSLHDLYDLEVDVPED
HAdV-4
59 V-PEVIDLTCHEAGFPPSDDEDEEG--------------------EEFVLDYVEHPGHGC
DPNEKAVNDLFSDAALLAAEEASSPSS--------DSDSSLHT----PRHDRGEKEIPGL
1 MRHLRDLPDEEIIIASGSEILELVVNATM-GDDHPEPP-TPFGTPSLHDLYDLEVDVPED
HAdV-12
101
DNNEQAVNEFFPESLILAASEGLFLPE--------P-PVL--SP---VCEPIGGECMPQL
MRHLRLLP---------------------------------------------------HAdV-9
9 H-PEDMDLLCYEMGFPCSDSEDEQDENGMAHVSASAAAAAADREREEFQLDHPELPGHNC
--------STVPESMILQADIANESTP-------------LHTPT--------LSPIPEL
1 MRHLRLLP---------------------------------------------------HAdV-40
90
DANQEAVDGMFPERLLSEAESAAESGS--------------------GDSGVG----EEL
MRHIICHGG-VITEEMAASLLDQLIEEVL-AD-NLPPP-SHFEPPTLHELYDLDVTAP-E
HAdV-5
56 L-PVDLDLKCYEDGLPPSDPETDEATEAEEEA---AMPTYVNENENELVLDCPENPGRGC
DPNEEAVSQIFPDSVMLAVQEGIDLLTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNL
1 MRHIICHGG-VITEEMAASLLDQLIEEVL-AD-NLPPP-SHFEPPTLHELYDLDVTAP-E
DPNEEAVNGFFTDSMLLAADEGLDINP--------P-PETLVTPGVVVESGIGGKKLPDL
HAdV-3
109
G-AAEMDLRCYEEGFPPSDDEDGETEQS-IHT---AVNEGVKAASDVFKLDCPELPGHGC
HAdV-52
84
DPNEDAVNSMFPECLFEAAEEGSHSSE------------------------------ESK
MRTEM-TPL-VLSYQEADDILEHLVDNFF-NE-VPSDD--DLYVPSLYELYDLDVESAGE
HAdV-12
55 R-GEELDLKCYEECLPSSDSETEQTGG----D---GCTEPV--VKNEPVLDRPDQPGHGC
DNNEQAVNEFFPESLILAASEGLFLPE--------P-PVL--SP---VCEPIGGECMPQL
1 MRTEM-TPL-VLSYQEADDILEHLVDNFF-NE-VPSDD--DLYVPSLYELYDLDVESAGE
HAdV-4
107 K-WEKMDLRCYEECLPPSDDEDEQAIQ----N---AASHGVQAVSESFALDCPPLPGHGC
DPNEKAVNDLFSDAALLAAEEASSPSS--------DSDSSLHT----PRHDRGEKEIPGL
MRMLPDFF----TGNW-DDMFQGLLETEYVFD-FPEPS-EASEEMSLHDLFDVEVDGFEE
HAdV-40
54 DANQEAVDGMFPERLLSEAESAAESGS--------------------GDSGVG----EEL
1 MRMLPDFF----TGNW-DDMFQGLLETEYVFD-FPEPS-EASEEMSLHDLFDVEVDGFEE
--------STVPESMILQADIANESTP-------------LHTPT--------LSPIPEL
HAdV-9
40 EEEDELDLRCYEEGFPPSDSEDER-----------------------------------MRLVPEMYG-VFCSET-VRNSDELLNTDL-LD-VPNSP--VTSPPSLHDLFDVEVDPP-Q
1 MRLVPEMYG-VFCSET-VRNSDELLNTDL-LD-VPNSP--VTSPPSLHDLFDVEVDPP-Q
HAdV-52
54 DPNEDAVNSMFPECLFEAAEEGSHSSE------------------------------ESK
DPNEEAVSQIFPDSVMLAVQEGIDLLTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNL
HAdV-5
116 KSCEFHRNNTGMKELLCSLCYMRMHCHFIYSPVSDDES--P------------------V-PEVIDLTCHEAGFPPSDDEDEEG--------------------EEFVLDYVEHPGHGC
HAdV-3
164
G-AAEMDLRCYEEGFPPSDDEDGETEQS-IHT---AVNEGVKAASDVFKLDCPELPGHGC
DNNEQAVNEFFPESLILAASEGLFLPE--------P-PVL--SP---VCEPIGGECMPQL
HAdV-12 159
101 KSCEFHRINTGDKAVLCALCYMRAYNHCVYSPVSDADDETP------------------H-PEDMDLLCYEMGFPCSDSEDEQDENGMAHVSASAAAAAADREREEFQLDHPELPGHNC
HAdV-4
K-WEKMDLRCYEECLPPSDDEDEQAIQ----N---AASHGVQAVSESFALDCPPLPGHGC
DANQEAVDGMFPERLLSEAESAAESGS--------------------GDSGVG----EEL
HAdV-40
90 ------------------------------GPVSEDELS-P------------------L-PVDLDLKCYEDGLPPSDPETDEATEAEEEA---AMPTYVNENENELVLDCPENPGRGC
HAdV-9
64
EEEDELDLRCYEEGFPPSDSEDER-----------------------------------DPNEEAVNGFFTDSMLLAADEGLDINP--------P-PETLVTPGVVVESGIGGKKLPDL
58 DPNEEAVNGFFTDSMLLAADEGLDINP--------P-PETLVTPGVVVESGIGGKKLPDL
HAdV-3
109
G-AAEMDLRCYEEGFPPSDDEDGETEQS-IHT---AVNEGVKAASDVFKLDCPELPGHGC
HAdV-52 155
84 R-GEELDLKCYEECLPSSDSETEQTGG----D---GCTEPV--VKNEPVLDRPDQPGHGC
DPNEDAVNSMFPECLFEAAEEGSHSSE------------------------------ESK
HAdV-5
V-PEVIDLTCHEAGFPPSDDEDEEG--------------------EEFVLDYVEHPGHGC
DPNEKAVNDLFSDAALLAAEEASSPSS--------DSDSSLHT----PRHDRGEKEIPGL
HAdV-4
107 RSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSPVSEPEPEPEPEPEPARPTRRPKMAPAIL
K-WEKMDLRCYEECLPPSDDEDEQAIQ----N---AASHGVQAVSESFALDCPPLPGHGC
59 DPNEKAVNDLFSDAALLAAEEASSPSS--------DSDSSLHT----PRHDRGEKEIPGL
HAdV-12
160
H-PEDMDLLCYEMGFPCSDSEDEQDENGMAHVSASAAAAAADREREEFQLDHPELPGHNC
--------STVPESMILQADIANESTP-------------LHTPT--------LSPIPEL
9 --------STVPESMILQADIANESTP-------------LHTPT--------LSPIPEL
HAdV-9
40 KSCEHHRNSTGNTDLMCSLCYLRAYNMFIYSPVSDNEPEPNST----------------EEEDELDLRCYEEGFPPSDSEDER-----------------------------------HAdV-40
146
L-PVDLDLKCYEDGLPPSDPETDEATEAEEEA---AMPTYVNENENELVLDCPENPGRGC
DPNEEAVSQIFPDSVMLAVQEGIDLLTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNL
56 DPNEEAVSQIFPDSVMLAVQEGIDLLTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNL
HAdV-5
116 RACDFHRGTSGNPEAMCALCYMRLTGHCIYSPISDAEGESES-----------------V-PEVIDLTCHEAGFPPSDDEDEEG--------------------EEFVLDYVEHPGHGC
G-AAEMDLRCYEEGFPPSDDEDGETEQS-IHT---AVNEGVKAASDVFKLDCPELPGHGC
HAdV-3
164
KSCEFHRNNTGMKELLCSLCYMRMHCHFIYSPVSDDES--P------------------1
MRHLRFLPQEVISSETGIEILEFVVNTLM-GD-DPEPPVQPFDPPTLHDLYDLEIDGP-E
HAdV-52
134
RACAFHRNASGNPETLCALCYLRLTSDFVYSDVSDAEGDGD------------------R-GEELDLKCYEECLPSSDSETEQTGG----D---GCTEPV--VKNEPVLDRPDQPGHGC
DNNEQAVNEFFPESLILAASEGLFLPE--------P-PVL--SP---VCEPIGGECMPQL
55 DNNEQAVNEFFPESLILAASEGLFLPE--------P-PVL--SP---VCEPIGGECMPQL
HAdV-12 101 H-PEDMDLLCYEMGFPCSDSEDEQDENGMAHVSASAAAAAADREREEFQLDHPELPGHNC
K-WEKMDLRCYEECLPPSDDEDEQAIQ----N---AASHGVQAVSESFALDCPPLPGHGC
HAdV-4
159
KSCEFHRINTGDKAVLCALCYMRAYNHCVYSPVSDADDETP------------------1
MRHLRDLPDEEIIIASGSEILELVVNATM-GDDHPEPP-TPFGTPSLHDLYDLEVDVPED
DANQEAVDGMFPERLLSEAESAAESGS--------------------GDSGVG----EEL
54 DANQEAVDGMFPERLLSEAESAAESGS--------------------GDSGVG----EEL
HAdV-40
90 L-PVDLDLKCYEDGLPPSDPETDEATEAEEEA---AMPTYVNENENELVLDCPENPGRGC
HAdV-9
64 ------------------------------GPVSEDELS-P------------------EEEDELDLRCYEEGFPPSDSEDER-----------------------------------1 MRHLRLLP---------------------------------------------------DPNEDAVNSMFPECLFEAAEEGSHSSE------------------------------ESK
54
DPNEDAVNSMFPECLFEAAEEGSHSSE------------------------------ESK
HAdV-52
84 R-GEELDLKCYEECLPSSDSETEQTGG----D---GCTEPV--VKNEPVLDRPDQPGHGC
V-PEVIDLTCHEAGFPPSDDEDEEG--------------------EEFVLDYVEHPGHGC
HAdV-5
155 ------------------SPDSTTSPPEIQAPAPANVCKPIPVKPKPGKRPAVDKLEDLL
RSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSPVSEPEPEPEPEPEPARPTRRPKMAPAIL
1 MRHIICHGG-VITEEMAASLLDQLIEEVL-AD-NLPPP-SHFEPPTLHELYDLDVTAP-E
HAdV-3
203
KSCEFHRNNTGMKELLCSLCYMRMHCHFIYSPVSDDES--P------------------H-PEDMDLLCYEMGFPCSDSEDEQDENGMAHVSASAAAAAADREREEFQLDHPELPGHNC
HAdV-12 200
160 ------------------TTESTLSPPEIGTSPSDNIVRPVPVRATG-RRAAVECLDDLL
KSCEHHRNSTGNTDLMCSLCYLRAYNMFIYSPVSDNEPEPNST----------------1 MRTEM-TPL-VLSYQEADDILEHLVDNFF-NE-VPSDD--DLYVPSLYELYDLDVESAGE
HAdV-4
KSCEFHRINTGDKAVLCALCYMRAYNHCVYSPVSDADDETP------------------L-PVDLDLKCYEDGLPPSDPETDEATEAEEEA---AMPTYVNENENELVLDCPENPGRGC
HAdV-40 146
RACDFHRGTSGNPEAMCALCYMRLTGHCIYSPISDAEGESES-----------------1 MRMLPDFF----TGNW-DDMFQGLLETEYVFD-FPEPS-EASEEMSLHDLFDVEVDGFEE
HAdV-9
74
------------------SEEDHPSPPELSGETPLQVFRPTPVRPSGERRAAVDKIEDLL
------------------------------GPVSEDELS-P------------------G-AAEMDLRCYEEGFPPSDDEDGETEQS-IHT---AVNEGVKAASDVFKLDCPELPGHGC
109
G-AAEMDLRCYEEGFPPSDDEDGETEQS-IHT---AVNEGVKAASDVFKLDCPELPGHGC
HAdV-3
164 KSCEFHRNNTGMKELLCSLCYMRMHCHFIYSPVSDDES--P------------------R-GEELDLKCYEECLPSSDSETEQTGG----D---GCTEPV--VKNEPVLDRPDQPGHGC
HAdV-52 215
134 RRPTSPVSRECNSSTDSCDSGPSNTPPEIHPVVPLCPIKPVAVRVGG-RRQAVECIEDLL
RACAFHRNASGNPETLCALCYLRLTSDFVYSDVSDAEGDGD------------------1
MRLVPEMYG-VFCSET-VRNSDELLNTDL-LD-VPNSP--VTSPPSLHDLFDVEVDPP-Q
HAdV-5
RSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSPVSEPEPEPEPEPEPARPTRRPKMAPAIL
K-WEKMDLRCYEECLPPSDDEDEQAIQ----N---AASHGVQAVSESFALDCPPLPGHGC
107 K-WEKMDLRCYEECLPPSDDEDEQAIQ----N---AASHGVQAVSESFALDCPPLPGHGC
HAdV-4
159 KSCEFHRINTGDKAVLCALCYMRAYNHCVYSPVSDADDETP------------------HAdV-12
203
KSCEHHRNSTGNTDLMCSLCYLRAYNMFIYSPVSDNEPEPNST----------------EEEDELDLRCYEEGFPPSDSEDER-----------------------------------40 EEEDELDLRCYEEGFPPSDSEDER-----------------------------------HAdV-9
64 -----------------LDGDERPSPPKLGSAVPEGVIKPVPQRVTGRRRCAVESILDLI
------------------------------GPVSEDELS-P------------------HAdV-40
188
RACDFHRGTSGNPEAMCALCYMRLTGHCIYSPISDAEGESES-----------------V-PEVIDLTCHEAGFPPSDDEDEEG--------------------EEFVLDYVEHPGHGC
116 V-PEVIDLTCHEAGFPPSDDEDEEG--------------------EEFVLDYVEHPGHGC
HAdV-5
155 --G---------------SPEDTDFPHPLTATPPHGIVRTIPCRVSCRRRPAVECIEDLL
RSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSPVSEPEPEPEPEPEPARPTRRPKMAPAIL
KSCEFHRNNTGMKELLCSLCYMRMHCHFIYSPVSDDES--P------------------HAdV-3
203 ------------------SPDSTTSPPEIQAPAPANVCKPIPVKPKPGKRPAVDKLEDLL
58 DPNEEAVNGFFTDSMLLAADEGLDINP--------P-PETLVTPGVVVESGIGGKKLPDL
HAdV-52
RACAFHRNASGNPETLCALCYLRLTSDFVYSDVSDAEGDGD------------------H-PEDMDLLCYEMGFPCSDSEDEQDENGMAHVSASAAAAAADREREEFQLDHPELPGHNC
101
H-PEDMDLLCYEMGFPCSDSEDEQDENGMAHVSASAAAAAADREREEFQLDHPELPGHNC
HAdV-12 175
160 ------------------RSGSANSPCTLGAVVPVGIIKPVAVRVSG-RRCAVEKLEDLL
KSCEHHRNSTGNTDLMCSLCYLRAYNMFIYSPVSDNEPEPNST----------------KSCEFHRINTGDKAVLCALCYMRAYNHCVYSPVSDADDETP------------------HAdV-4
200
------------------TTESTLSPPEIGTSPSDNIVRPVPVRATG-RRAAVECLDDLL
59
DPNEKAVNDLFSDAALLAAEEASSPSS--------DSDSSLHT----PRHDRGEKEIPGL
L-PVDLDLKCYEDGLPPSDPETDEATEAEEEA---AMPTYVNENENELVLDCPENPGRGC
90 L-PVDLDLKCYEDGLPPSDPETDEATEAEEEA---AMPTYVNENENELVLDCPENPGRGC
HAdV-40 146 RACDFHRGTSGNPEAMCALCYMRLTGHCIYSPISDAEGESES-----------------------------------------------GPVSEDELS-P------------------HAdV-9
74
------------------SEEDHPSPPELSGETPLQVFRPTPVRPSGERRAAVDKIEDLL
9
--------STVPESMILQADIANESTP-------------LHTPT--------LSPIPEL
R-GEELDLKCYEECLPSSDSETEQTGG----D---GCTEPV--VKNEPVLDRPDQPGHGC
84 R-GEELDLKCYEECLPSSDSETEQTGG----D---GCTEPV--VKNEPVLDRPDQPGHGC
HAdV-52 134 RACAFHRNASGNPETLCALCYLRLTSDFVYSDVSDAEGDGD------------------HAdV-5
215 EG----GDGPLDLS-TRKLPR-Q
RRPTSPVSRECNSSTDSCDSGPSNTPPEIHPVVPLCPIKPVAVRVGG-RRQAVECIEDLL
RSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSPVSEPEPEPEPEPEPARPTRRPKMAPAIL
1 MRHLRFLPQEVISSETGIEILEFVVNTLM-GD-DPEPPVQPFDPPTLHDLYDLEIDGP-E
56
DPNEEAVSQIFPDSVMLAVQEGIDLLTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNL
HAdV-3
245
------------------SPDSTTSPPEIQAPAPANVCKPIPVKPKPGKRPAVDKLEDLL
KSCEHHRNSTGNTDLMCSLCYLRAYNMFIYSPVSDNEPEPNST----------------HAdV-12 241
203 QGG----DEPLDLCTRK-RPR-H
-----------------LDGDERPSPPKLGSAVPEGVIKPVPQRVTGRRRCAVESILDLI
1 MRHLRDLPDEEIIIASGSEILELVVNATM-GDDHPEPP-TPFGTPSLHDLYDLEVDVPED
55
DNNEQAVNEFFPESLILAASEGLFLPE--------P-PVL--SP---VCEPIGGECMPQL
HAdV-4
------------------TTESTLSPPEIGTSPSDNIVRPVPVRATG-RRAAVECLDDLL
RACDFHRGTSGNPEAMCALCYMRLTGHCIYSPISDAEGESES-----------------HAdV-40 116
188 QDMG--GDEPLDLS-LK-RPR-N
--G---------------SPEDTDFPHPLTATPPHGIVRTIPCRVSCRRRPAVECIEDLL
1 MRHLRLLP---------------------------------------------------54
DANQEAVDGMFPERLLSEAESAAESGS--------------------GDSGVG----EEL
HAdV-9
------------------SEEDHPSPPELSGETPLQVFRPTPVRPSGERRAAVDKIEDLL
KSCEFHRNNTGMKELLCSLCYMRMHCHFIYSPVSDDES--P------------------164
KSCEFHRNNTGMKELLCSLCYMRMHCHFIYSPVSDDES--P------------------HAdV-3
203
------------------SPDSTTSPPEIQAPAPANVCKPIPVKPKPGKRPAVDKLEDLL
RACAFHRNASGNPETLCALCYLRLTSDFVYSDVSDAEGDGD------------------HAdV-52 274
175 NEP----GQPLDLS-CK-RPR-P
------------------RSGSANSPCTLGAVVPVGIIKPVAVRVSG-RRCAVEKLEDLL
1 MRHIICHGG-VITEEMAASLLDQLIEEVL-AD-NLPPP-SHFEPPTLHELYDLDVTAP-E
54
DPNEDAVNSMFPECLFEAAEEGSHSSE------------------------------ESK
HAdV-5
RRPTSPVSRECNSSTDSCDSGPSNTPPEIHPVVPLCPIKPVAVRVGG-RRQAVECIEDLL
KSCEFHRINTGDKAVLCALCYMRAYNHCVYSPVSDADDETP------------------159
KSCEFHRINTGDKAVLCALCYMRAYNHCVYSPVSDADDETP------------------HAdV-4
200 ------------------TTESTLSPPEIGTSPSDNIVRPVPVRATG-RRAAVECLDDLL
1 MRTEM-TPL-VLSYQEADDILEHLVDNFF-NE-VPSDD--DLYVPSLYELYDLDVESAGE
HAdV-12 246 QEEEREQTVPVDLS-VK-RPRCN
-----------------LDGDERPSPPKLGSAVPEGVIKPVPQRVTGRRRCAVESILDLI
------------------------------GPVSEDELS-P------------------64 ------------------------------GPVSEDELS-P------------------HAdV-9
74 ------------------SEEDHPSPPELSGETPLQVFRPTPVRPSGERRAAVDKIEDLL
1 MRMLPDFF----TGNW-DDMFQGLLETEYVFD-FPEPS-EASEEMSLHDLFDVEVDGFEE
HAdV-40 231 EEDP--TDEPLNLS-LK-RPKCS
--G---------------SPEDTDFPHPLTATPPHGIVRTIPCRVSCRRRPAVECIEDLL
RSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSPVSEPEPEPEPEPEPARPTRRPKMAPAIL
155 RSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSPVSEPEPEPEPEPEPARPTRRPKMAPAIL
HAdV-5
215 RRPTSPVSRECNSSTDSCDSGPSNTPPEIHPVVPLCPIKPVAVRVGG-RRQAVECIEDLL
------------------SPDSTTSPPEIQAPAPANVCKPIPVKPKPGKRPAVDKLEDLL
HAdV-3
245 QEE---QTEPLDLS-MK-RPKLT
EG----GDGPLDLS-TRKLPR-Q
1 MRLVPEMYG-VFCSET-VRNSDELLNTDL-LD-VPNSP--VTSPPSLHDLFDVEVDPP-Q
109
G-AAEMDLRCYEEGFPPSDDEDGETEQS-IHT---AVNEGVKAASDVFKLDCPELPGHGC
HAdV-52
216
------------------RSGSANSPCTLGAVVPVGIIKPVAVRVSG-RRCAVEKLEDLL
KSCEHHRNSTGNTDLMCSLCYLRAYNMFIYSPVSDNEPEPNST----------------160 KSCEHHRNSTGNTDLMCSLCYLRAYNMFIYSPVSDNEPEPNST----------------HAdV-12
203
------------------TTESTLSPPEIGTSPSDNIVRPVPVRATG-RRAAVECLDDLL
HAdV-4
241 -----------------LDGDERPSPPKLGSAVPEGVIKPVPQRVTGRRRCAVESILDLI
QGG----DEPLDLCTRK-RPR-H
107
K-WEKMDLRCYEECLPPSDDEDEQAIQ----N---AASHGVQAVSESFALDCPPLPGHGC
RACDFHRGTSGNPEAMCALCYMRLTGHCIYSPISDAEGESES-----------------146 RACDFHRGTSGNPEAMCALCYMRLTGHCIYSPISDAEGESES-----------------HAdV-40
188
------------------SEEDHPSPPELSGETPLQVFRPTPVRPSGERRAAVDKIEDLL
HAdV-9
116 --G---------------SPEDTDFPHPLTATPPHGIVRTIPCRVSCRRRPAVECIEDLL
QDMG--GDEPLDLS-LK-RPR-N
40 RACAFHRNASGNPETLCALCYLRLTSDFVYSDVSDAEGDGD------------------EEEDELDLRCYEEGFPPSDSEDER-----------------------------------RACAFHRNASGNPETLCALCYLRLTSDFVYSDVSDAEGDGD------------------134
HAdV-52
175
RRPTSPVSRECNSSTDSCDSGPSNTPPEIHPVVPLCPIKPVAVRVGG-RRQAVECIEDLL
HAdV-5
274 ------------------RSGSANSPCTLGAVVPVGIIKPVAVRVSG-RRCAVEKLEDLL
NEP----GQPLDLS-CK-RPR-P
58 DPNEEAVNGFFTDSMLLAADEGLDINP--------P-PETLVTPGVVVESGIGGKKLPDL
116
V-PEVIDLTCHEAGFPPSDDEDEEG--------------------EEFVLDYVEHPGHGC
EG----GDGPLDLS-TRKLPR-Q
HAdV-12 246 QEEEREQTVPVDLS-VK-RPRCN
-----------------LDGDERPSPPKLGSAVPEGVIKPVPQRVTGRRRCAVESILDLI
59 DPNEKAVNDLFSDAALLAAEEASSPSS--------DSDSSLHT----PRHDRGEKEIPGL
101
H-PEDMDLLCYEMGFPCSDSEDEQDENGMAHVSASAAAAAADREREEFQLDHPELPGHNC
QGG----DEPLDLCTRK-RPR-H
--G---------------SPEDTDFPHPLTATPPHGIVRTIPCRVSCRRRPAVECIEDLL
HAdV-40 231 EEDP--TDEPLNLS-LK-RPKCS
9 --------STVPESMILQADIANESTP-------------LHTPT--------LSPIPEL
90
L-PVDLDLKCYEDGLPPSDPETDEATEAEEEA---AMPTYVNENENELVLDCPENPGRGC
QDMG--GDEPLDLS-LK-RPR-N
------------------SPDSTTSPPEIQAPAPANVCKPIPVKPKPGKRPAVDKLEDLL
203
------------------SPDSTTSPPEIQAPAPANVCKPIPVKPKPGKRPAVDKLEDLL
HAdV-3
------------------RSGSANSPCTLGAVVPVGIIKPVAVRVSG-RRCAVEKLEDLL
HAdV-52 245
216 EG----GDGPLDLS-TRKLPR-Q
QEE---QTEPLDLS-MK-RPKLT
56
84 DPNEEAVSQIFPDSVMLAVQEGIDLLTFPPAPGSPEPPHLSRQPEQPEQRALGPVSMPNL
R-GEELDLKCYEECLPSSDSETEQTGG----D---GCTEPV--VKNEPVLDRPDQPGHGC
NEP----GQPLDLS-CK-RPR-P
------------------TTESTLSPPEIGTSPSDNIVRPVPVRATG-RRAAVECLDDLL
200
------------------TTESTLSPPEIGTSPSDNIVRPVPVRATG-RRAAVECLDDLL
HAdV-4
241 QGG----DEPLDLCTRK-RPR-H
55
DNNEQAVNEFFPESLILAASEGLFLPE--------P-PVL--SP---VCEPIGGECMPQL
QEEEREQTVPVDLS-VK-RPRCN
------------------SEEDHPSPPELSGETPLQVFRPTPVRPSGERRAAVDKIEDLL
74 ------------------SEEDHPSPPELSGETPLQVFRPTPVRPSGERRAAVDKIEDLL
HAdV-9
116 QDMG--GDEPLDLS-LK-RPR-N
54 DANQEAVDGMFPERLLSEAESAAESGS--------------------GDSGVG----EEL
EEDP--TDEPLNLS-LK-RPKCS
RRPTSPVSRECNSSTDSCDSGPSNTPPEIHPVVPLCPIKPVAVRVGG-RRQAVECIEDLL
215 RRPTSPVSRECNSSTDSCDSGPSNTPPEIHPVVPLCPIKPVAVRVGG-RRQAVECIEDLL
HAdV-5
274 NEP----GQPLDLS-CK-RPR-P
EG----GDGPLDLS-TRKLPR-Q
54 DPNEDAVNSMFPECLFEAAEEGSHSSE------------------------------ESK
164
KSCEFHRNNTGMKELLCSLCYMRMHCHFIYSPVSDDES--P------------------QEE---QTEPLDLS-MK-RPKLT
-----------------LDGDERPSPPKLGSAVPEGVIKPVPQRVTGRRRCAVESILDLI
203 -----------------LDGDERPSPPKLGSAVPEGVIKPVPQRVTGRRRCAVESILDLI
HAdV-12 246 QEEEREQTVPVDLS-VK-RPRCN
QGG----DEPLDLCTRK-RPR-H
159
KSCEFHRINTGDKAVLCALCYMRAYNHCVYSPVSDADDETP--------------------G---------------SPEDTDFPHPLTATPPHGIVRTIPCRVSCRRRPAVECIEDLL
188 --G---------------SPEDTDFPHPLTATPPHGIVRTIPCRVSCRRRPAVECIEDLL
HAdV-40 231 EEDP--TDEPLNLS-LK-RPKCS
QDMG--GDEPLDLS-LK-RPR-N
64 ------------------------------GPVSEDELS-P------------------------------------RSGSANSPCTLGAVVPVGIIKPVAVRVSG-RRCAVEKLEDLL
175
------------------RSGSANSPCTLGAVVPVGIIKPVAVRVSG-RRCAVEKLEDLL
HAdV-52 216 QEE---QTEPLDLS-MK-RPKLT
NEP----GQPLDLS-CK-RPR-P
109
G-AAEMDLRCYEEGFPPSDDEDGETEQS-IHT---AVNEGVKAASDVFKLDCPELPGHGC
155 RSCHYHRRNTGDPDIMCSLCYMRTCGMFVYSPVSEPEPEPEPEPEPARPTRRPKMAPAIL
QEEEREQTVPVDLS-VK-RPRCN
107
K-WEKMDLRCYEECLPPSDDEDEQAIQ----N---AASHGVQAVSESFALDCPPLPGHGC
160 KSCEHHRNSTGNTDLMCSLCYLRAYNMFIYSPVSDNEPEPNST----------------EEDP--TDEPLNLS-LK-RPKCS
40 RACDFHRGTSGNPEAMCALCYMRLTGHCIYSPISDAEGESES-----------------EEEDELDLRCYEEGFPPSDSEDER-----------------------------------146
EG----GDGPLDLS-TRKLPR-Q
245
EG----GDGPLDLS-TRKLPR-Q
QEE---QTEPLDLS-MK-RPKLT
116
V-PEVIDLTCHEAGFPPSDDEDEEG--------------------EEFVLDYVEHPGHGC
134
RACAFHRNASGNPETLCALCYLRLTSDFVYSDVSDAEGDGD------------------QGG----DEPLDLCTRK-RPR-H
241 QGG----DEPLDLCTRK-RPR-H
101 H-PEDMDLLCYEMGFPCSDSEDEQDENGMAHVSASAAAAAADREREEFQLDHPELPGHNC
QDMG--GDEPLDLS-LK-RPR-N
116 QDMG--GDEPLDLS-LK-RPR-N
90 L-PVDLDLKCYEDGLPPSDPETDEATEAEEEA---AMPTYVNENENELVLDCPENPGRGC
NEP----GQPLDLS-CK-RPR-P
274 NEP----GQPLDLS-CK-RPR-P
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Figure 1.6 Small linear motifs within conserved region 2 of HAdV-5. Amino acid
residues 108-139 of HAdV-5 E1A. The PXLXP, EVIDLT and LXCXE motifs are
highlighted with their reported binding partners BS69, UBC9, and pRB.
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1.10 E1A and Innate Immune evasion
With respect to immune evasion strategies, the first indication that E1A could block IFN
signaling was in 1988 when Reich and colleagues used E1A-deletion mutagenesis
experiments to demonstrate that E1A blocks interferon signaling in infected HeLa cells.
This was followed up with mapping studies that indicated the N-terminus was responsible
for modulating transcriptional activation of IFN target genes (Kalvakolanu et al., 1991;
Anderson and Fennie, 1987). In 2012, Fonseca and colleagues showed how E1A disrupts
the transcription of intereferon stimulatory genes (ISGs) by antagonizing chromatin
remodeling complexes. How E1A antagonizes the primary type I IFN response is less well
understood. As mentioned previously, Lau and colleagues (2015) proposed that E1A can
antagonize the STING pathway. A detailed mechanism of this antagonism has not been
elucidated and many questions regarding the consequences of this interaction remain.
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1.11

Rationale, Hypothesis, and Objectives

Since the discovery of the cytoplasmic DNA sensor cGAS in 2012, extensive research has
been undertaken to elucidate how the cGAS-STING pathway limits viral replication. In
equal measure, the vast array of evasion strategies employed by viruses to prevent a
primary interferon response has also been studied. The ability of a virus to escape innate
immune detection is paramount to its survival. HAdV-5 E1A was identified as an
antagonist of the cGAS-STING DNA sensing pathway by the group of Stetson in 2015
(Lau et al., 2015). They proposed that a small linear LXCXE motif encoded by HAdV-5
E1A could mediate an interaction with STING in the cytoplasm. However, the nature of
this protein-protein interaction is poorly understood and its conservation across Adenoviral
species is unknown. This LXCXE motif was previously identified for its role in mediating
the interaction between E1A and pRb in the nucleus. The potential for this motif to have
dual function requires further investigation and multiple motifs are likely required for
stable binding between E1A and STING. Therefore, and I set out to characterize the
interaction between E1A and STING.
In 2016, the group of Lichty (Wang et al., 2016) identified S6K1 as an additional binding
partner of the STING-TBK1-IRF3 complex. S6K1 is a mTORC1 substrate and their study
supports work by Hasan et al. (2016) that established a TBK1-mTORC1 regulatory axis
between cell intrinsic immunity and metabolism. The suppression of mTORC1 activity by
TBK1 during chronic STING activation, and the known interaction between S6K1 and
STING led me to question if E1A targets S6K1 function. The nature of the relationship
between E1A and S6K1 is currently unknown. Therefore, I set out to determine if E1A
interacts with S6K1, and potentially the S6K1-STING-TBK1-IRF3 complex.
Based on the rationale, I hypothesize that antagonism of the STING-pathway by adenovirus
E1A requires the LXCXE motif, in conjunction with additional E1A motifs that also
mediate binding with S6K1. To test my hypothesis, I have formed two objectives:
1. Characterize the interaction between E1A and STING and determine the
conservation of this interaction in different human Adenoviral species.
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2. Determine if E1A interacts with S6K1 in complex with STING.
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Chapter 2
2

Materials and Methods

2.1

Cell Culture

Human Embryonic Kidney 293 (HEK293) cells, HT1080 human fibrosarcoma cells, IMR90 primary human lung fibroblast cells, and A549 human alveolar basal epithelia cells were
all derived from frozen laboratory stocks and cultured in Dulbecco’s Modified Eagle’s
Medium (Multicell) supplemented with 10% calf serum (Gibco) and 1% PenStrep
(100U/ml Penicillin and 100µg/mL Streptomycin, Multicell). Cells were cultured at 37°C
with 5% CO2.

2.2 Plasmids
HAdV E1A plasmids were prepared and constructed by myself, and other (past and
present) members of the laboratory (Table 2.1)( * indicates plasmids I modified, subcloned, or constructed myself). E1A mutants were generated by PCR-based mutagenesis
or sub-cloned into the appropriate vectors. E1A mutants were either tagged with GFP or
contained no tag and cloned into pcDNA3.1 vectors. The human STING open reading
frame was synthesized by Integrated DNA Technologies (gBlocks Gene Fragments) and
generated with a C-terminal haemagglutinin (HA) epitope tag. The STING-HA fragment
was subsequently cloned into a pcDNA3.1 vector. The mouse S6K1-HA plasmid was
kindly gifted from Brian Lichty (McMaster University). S6K2 and RPS6 open reading
frames were synthesized by ThermoFisher (GeneArt Cloning Service) and cloned into
pcDNA3.1 vectors.
Transformation of all plasmids were conducted using competent DH5α E.coli grown in
Luria Broth (LB) supplemented with ampicillin (50µg/ml, BioShop) or kanamycin
(20µg/ml, Bioshop). Large scale plasmid purification was conducted using the PureLink
HiPure Plasmid Midiprep kit (Invitrogen).
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Table 2.1 List of plasmids used in this study.
#

Name

Parent Vector

Characteristics

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41

GFP-13S Ad3
GFP-13S Ad4
GFP-13S Ad5
GFP-13S Ad9
GFP-13S Ad12
GFP-13S Ad40
GFP-13S Ad52
GFP-12S
GFP-11S
GFP-10S *
GFP-N-terminus *
GFP-CR2
GFP-CR3 *
GFP-C-terminus *
GFP- N-terminus
GFP- N-terminus
GFP- N-terminus
GFP- N-terminus
GFP-N-terminus (∆4-25) *
GFP-N-terminus (∆26-35)
GFP-N-terminus (∆30-49)
GFP-∆N-terminus *
GFP-dl1105
GFP-dl1106
GFP-dl1107
GFP-dl1108
GFP-dl1109
13S Ad5 *
dl1106
dl1107 *
dl1108 *
GFP- Ad3 N-terminus
GFP- Ad5 N-terminus
GFP- Ad9 N-terminus
GFP- Ad12 N-terminus
GFP- Ad40 N-terminus
GFP- Ad52 N-terminus
Human HA-STING *
Mouse HA-S6K1
S6K2 *
RPS6 *

pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pcDNA3.1
pcDNA3.1
pcDNA3.1
pcDNA3.1
pGFP
pGFP
pGFP
pGFP
pGFP
pGFP
pcDNA3.1
pcDNA3.1
pcDNA3.1
pcDNA3.1

Full length 13S E1A of Ad3
Full length 13S E1A of Ad4
Full length 13S E1A of Ad5
Full length 13S E1A of Ad9
Full length 13S E1A of Ad12
Full length 13S E1A of Ad40
Full length 13S E1A of Ad52
12S E1A of Ad5
11S E1A of Ad5
10S E1A of Ad5
AA 1-80 of Ad5 E1A
AA 93-139 of Ad5 E1A
AA 139-204 of Ad5 E1A
AA 187-289 of Ad5 E1A
AA 1-14 of Ad5 E1A
AA 14-22 of Ad5 E1A
AA 16-22 of Ad5 E1A
AA 29-49 of Ad5 E1A
Plasmid #11 with ∆4-25
Plasmid #11 with ∆26-35
Plasmid #11 with ∆30-49
Plasmid #3 with ∆1-80
Plasmid #3 with ∆70-81
Plasmid #3 with ∆90-105
Plasmid #3 with ∆111-123
Plasmid #3 with ∆124-127
Plasmid #3 with ∆128-138
Full length 13S E1A of Ad5
Plasmid #28 with ∆90-105
Plasmid #28 with ∆111-123
Plasmid #28 with ∆30-49
AA 1-14 of Ad3
AA 1-14 of Ad5
AA 1-14 of Ad9
AA 1-14 of Ad12
AA 1-14 of Ad40
AA 1-14 of Ad52
Full length STING
Full length mS6K1
Full length S6K2
Full length RPS6
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2.3 Plasmid Transfections
All transfections and co-immunoprecipitation assays were conducted in 10cm dishes
(Sarstedt). HT1080 cells were seeded at 2 x 106 cells prior to transfection the following
day with 5 µg of STING-HA expression constructs, 5 µg of full length E1A-GFP, 5 µg of
E1A deletion mutants (Table 2.1), 5 µg of mouse S6K1-HA, 5 µg of human S6K2, 5 µg of
human RPS6, 5 µg GFP, or 5 µg pcDNA3.
Transfections were conducted using X-tremeGene HP DNA Transfection Reagent (Roche,
6366244001) according to the manufacturer’s protocol. HEK293 cells were seeded at 2.5
x 106 cells prior to transfection the following day with 5 µg STING-HA, 5 µg full length
E1A, 5 µg E1A deletion mutants, or 5 µg E1A-GFP.The pRb-GFP plasmid was used as a
positive technical control, the 13S-GFP and 13S-pcDNA3.1 plasmids were used as positive
controls, and the GFP and pcDNA3.1 plasmids were used as negative controls.

2.4 Co-Immunoprecipitation
Cells were harvested 24 hr post-transfection and pelleted by centrifugation at 500 RCF for
3 minutes at 4°C. The cells were then washed with phosphate buffered saline (PBS)
(4.2mM Na2HPO4, 2.7mM KCl, 173mM NaCl, and 1.5mM KH2PO4 (BioShop)). Cellular
pellets were lysed at 4°C with 0.8mL NP-40 lysis buffer (0.5% NP-40, 150mM NaCl, and
50mM Tris-HCl, pH 7.8 (BioShop) supplemented with 0.6% Mammalian Tissue Protease
Inhibitor Cocktail (Sigma). The lysate was then centrifuged and 2% of the supernatant was
aliquoted for sample input control. Sepharose-Protein A beads were transferred to the cell
lysate in addition to either anti-HA antibody, anti-GFP antibody, anti-STING antibody,
anti-E1A (M73 and M58) antibody, or anti-RPS6 antibody (Table 2.2). The samples were
then rotated at 4°C for either 4 hr or overnight. Samples were then washed 3 to 5 times
with NP-40 lysis buffer. The samples were then re-suspended in LDS sample buffer (2X,
NuPage; Thermo Fisher) and 0.2M DTT (BioShop) before being denatured at 98°C for 10
min.
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Table 2.2 List of antibodies used in this study.
Specificity

Description
Rabbit
polyclonal
Rat
monoclonal

E1A (M58)
Epitope: 1120 AA
E1A (M73)
Epitope: 271289 AA
STING
D2P2F

GFP
HA

Usage

Company

Primary

Clontech

Primary/IP

Roche

Mouse
monoclonal

Primary/IP

In house
hybridoma

Mouse
monoclonal

Primary/IP

In house
hybridoma

N/A

Primary/IP

Cell Signaling

13647

Primary/IP

Cell Signaling

2708

Primary/IP

Cell Signaling

2217

Primary

Sigma

Actin

Rabbit
monoclonal
Rabbit
polyclonal
Rabbit
monoclonal
Rabbit
polyclonal

Rat IgG

Goat

Secondary

Thermo
Scientific

Rabbit IgG

Goat

Secondary

Santa Cruz

Mouse IgG

Rabbit

Secondary

Santa Cruz

HA
12CA5

Mouse
monoclonal

IP

In house
hybridoma

S6K
RPS6
5G10

Catalogue #
632592
11867423001
N/A

M-7023
31470
Sc-2004
Sc-358923
N/A

Note: Antibodies used for immunoprecipitations were added directly to the cell lysate.
Primary and secondary antibodies are diluted in 5% w/v Skim Milk with TBS-T or 3%
BSA with TBS-T.
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2.5 Western Blotting Analysis
Samples were prepared and loaded into NuPAGE 10% or 4-12% Bis-Tris polyacrylamide
gels (Invitrogen). Resolution by electrophoresis was at 200V with MES running buffer
(50mM MES, 50mM Tris, 3.47mM SDS, and 1.03mM EDTA (BioShop)) and samples
were transferred to polyvinylidene fluoride (PVDF) membrane (Amersham Hybond, GE
Healthcare Life Science) with trasnfer buffer (25mM Bicine, 25mM Bis-Tris, 1.03mM
EDTA, 20nM Chlorobutanol, and 10% Methanol (BioBasic)). The membrane was blocked
for 1hr at room temperature with 5% w/v Skim Milk Powder (BioShop) in TBS-T (20mM
Tris, 136mM NaCl (BioShop)), and 0.1% Tween-20 (Sigma). Primary antibodies (Table
2.2) were diluted in either 5% w/v Skim Milk in TBS-T, or 3% Bovine Serum Albumin
(Sigma) in TBS-T. Membranes were washed with TBS-T before appropriately diluted
secondary antibodies (Table 2.2) were applied for 1hr at room temperature. Luminanta
Crescendo Western horseradish peroxidase (HRP) Substrate or Forte Cresendo Western
HRP Substrate (Millipore) were used to detect protein according to the manufacturer’s
protocol.

Images

were

developed

on

the

Amersham

Hyperfilm

Enhanced

Chemiluminescence (ECL) membrane (GE Healthcare) with the Konica Minolta SRX101A automated film processor according to the manufacturer’s protocol.

2.6 Statistical Analysis
Each co-immunoprecipitation experiment was replicated either two or three times.
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Chapter 3
3.1

Mapping the Interaction Between HAdV-5 E1A and

STING
Identifying and defining the regions of HAdV E1A that mediate interaction with STING
can provide insight into the nature of this protein-protein interaction. Lau et al. (2015)
suggested that the E1A LXCXE motif is necessary and sufficient for this interaction, but by
drawing comparisons to the functional importance of the E1A LXCXE-mediated
interaction with pRb, the possibility of a multi-region interaction cannot be dismissed. The
LXCXE motif can be found in several viral and cellular proteins, with several of the latter
showing mixed capacity and transient binding for pRb. Structural analysis of LXCXE
motifs from multiple proteins revealed the importance of the side chain residues in making
strong hydrophobic interactions with the target domains. Structural analysis has shown that
the highly positive surface of the pRb domain LXCXE binding cleft repels the positive
residues in the LXCXE motif and flanking residues (Singh et al., 2005). Therefore, analysis
of the interaction between E1A and STING should be extended beyond the 5 amino acid
residue LXCXE motif.

3.1.1 HAdV-5 E1A Major Isoforms Bind STING
Differential splicing of E1A produces multiple isoforms of varying length, which form at
certain stages of infection. The 5 major isoforms (Figure 3.1A) have mRNA sedimentation
rates of 13S, 12S, 11S, 10S, and 9S and consist of 289 residues (R), 243R, 217R, 171R,
and 55R respectively (Figure 3.1A). The 13S and 12S major isoforms are expressed in the
early phases of infection, while the 11S, 10S, and 9s follow later in infection (Perricaudet
et al., 1979; Stephens & Harlow, 1987). Analyzing the interaction between STING and the
E1A isoforms allows for a general mapping of the interaction, revealing key deductions.
For example, the 12S isoform does not contain the CR3 region. Four isoforms of E1A,
namely 13S, 12S, 11S and 10S were prepared in GFP-tagged constructs for co-transfection
with the HA-tagged STING construct. HT1080 cells were co-transfected with HA-tagged
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A

AAA 9S (55R)
LXCXE

Figure 3.1. STING binds the four largest isoforms of HAdV-5 E1A. (A) Diagram
depicting the structure of E1A mRNA transcripts. Boxes represent the coding regions,
which are all read in the same frame, with the exception of 9S (Figure adapted with
permission from Dr. Joe Mymryk, Western University, unpublished data) (B) HT1080
cells were transfected with 5 µg human STING-HA expression vector and 5 µg of either
13S-GFP, 12S-GFP, 11S-GFP, or 10S-GFP E1A expression vector. After 24 hr, cells
were harvested and lysed, followed by immunoprecipitation of HA and western blotting
for GFP-tagged E1A proteins. GFP was used as a control and pRb-HA was used as a
technical positive. IgG HC denotes the heavy chain. IgG LC denotes the light chain.
Inputs shown in the bottom panel. Results representative of three independent
experiments.
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STING and GFP-tagged 13S, 12S, 11S, 10S, E1A from HAdV-5. A plasmid encoding HA
tagged pRb was used as a technical positive control for interaction with E1A.
Our laboratory has previously demonstrated that an E1A CR2 construct possessing the
LXCXE motif forms a strong interaction with pRb in co-immunoprecipitation experiments
(unpublished data). After 24 hr, cells were harvested and lysed, followed by
immunoprecipitation of HA. Western blotting using anti-GFP polyclonal antibody
demonstrated that all four HAdV-5 E1A isoforms tested could interact with STING in vitro
(Figure 3.1B). All four isoforms contain the LXCXE motif, so this result is within
agreement with the prediction made by Lau and colleagues (2015). However, these E1A
isoforms also share common regions within the N-terminus and CR4 region.

3.1.2 HAdV-5 E1A N-terminus Region Binds STING
To better map the region of interaction on HAdV-5 E1A, I performed a series of coimmunoprecipitation experiments using mutants encompassing the conserved regions of
HAdV-5 E1A (Figure 3.2A). HT1080 cells were co-transfected with STING-HA and the
following GFP-tagged 13S E1A mutants: 1-82 AA, which contains the N-terminal region
and CR1 residues (42-72AA); 93-139AA which spans CR2 (116-139); 187-289AA which
spans

CR3

(144-191);

and

187-289AA

which

spans

CR4

(240-288AA).

Immunoprecipitation of STING was followed by western blotting with polyclonal antiGFP antibody (Figure 3.2B). Consistent with Figure 3.1B, STING-HA binds to the Nterminal region of HAdV-5. However, this contradicts the notion that the LXCXE motif is
necessary and sufficient for E1A-STING binding as the LXCXE motif is located within
the CR2 region.

3.1.3

Assessing the Interaction Between STING and the

Extreme N-terminus Region of E1A
To further analyze and map the region of HAdV-5 E1A required for interaction with
STING, multiple E1A constructs were generated that spanned the N-terminus. E1A
constructs consisted of amino acid residues 1-14AA, 14-22AA, 16-22AA, and 19-49AA.
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Figure 3.2. STING binds to the HAdV-5 E1A N-terminus and CR1. (A) Diagram
depicting the conserved amino acid regions (CRs) of human adenovirus E1A. (B)
HT1080 cells were transfected with 5 µg of human STING-HA expression vector and
5 µg of either N terminus-GFP, CR2-GFP, CR3-GFP, or C terminus-GFP E1A
expression vector. After 24 hr, cells were harvested and lysed, followed by
immunoprecipitation of STING and western blotting for GFP-tagged E1A proteins.
GFP was used as a control with STING-HA. IgG HC denotes the heavy chain. Inputs
shown in the bottom panel. Results representative of three independent experiments.
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Co-immunoprecipitation experiments were conducted in HT1080 cells using anti-STING
antibody, followed by western blotting with anti- GFP antibody. The first 14 amino acid
residues of E1A were found to bind STING, while E1A amino acid residues 29-49 were
found to mediate a much weaker binding, as indicated by a faint signal (Figure 3.3A).
However, this 29-49AA mutant was present at a much higher concentration within the
lysate (as shown by the input), potentially producing a false-positive result. This finding
was consistent with earlier results indicating that the N-terminus was an important region
of interaction between E1A and STING.
To further verify that the region of HAdV-5 E1A was required for binding STING in vitro,
deletion mutants were prepared by removing stretches of amino acids within the N-terminal
backbone (Figure 3.3B). These small deletion mutants of E1A are well characterized and
the biological effects of these mutations have been studied in different models (Jelsma et
al., 1988). The dl1101 mutant contains deletion of amino acid residues 4-25, the dl1102
mutant contains deletion of amino acid residues 26-35, and the dl1103 mutant contains the
deletion of amino acid residues 30-49. As Figure 3.3C indicates, the WT N-terminus and
dl1103 E1A mutants were found to bind STING, while dl1101 and dl1102 had significantly
reduced/non-detectable binding. This is consistent with the previous finding that the first
14 amino acid residues were of particular importance for interaction. This also supports
the hypothesis that the LXCXE motif is not sufficient for interaction. As the dl1103 mutant
was also found to bind STING, it supports the earlier suggestion that the N-terminal amino
acid residues 29-49 do not play significant roles in mediating the interaction.

3.1.4 The HAdV-5 LXCXE Motif is Not Necessary for Binding
STING
The suggestion by Lau et al. (2015) that the LXCXE motif was the point of interaction
between HAdV-5 E1A and STING in HEK293 cells requires further investigation.
HEK293 cells were immortalized by HAdV-5 E1A, and therefore express the E1A protein
(Thomas & Smart, 2005). Despite the presence of endogenous E1A, Lau and colleagues
co-transfected HEK293 cells with STING and an E1A construct containing mutations that
disabled the LXCXE motif. They reported that these mutations within the LXCXE motif
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Figure 3.3. STING binds the Extreme N-terminus of HAdV-5 E1A. (A) HT1080
cells were transfected with 5 µg of human STING-HA expression vector and 5 µg of N
terminus-GFP E1A expression vector mutants; 1-14AA, 14-22AA, 16-22AA, and 2949AA. After 24 hr, cells were harvested and lysed, followed by immunoprecipitation of
STING and western blotting for GFP-tagged E1A mutants with anti-GFP antibody. GFP
was used as a control with STING-HA. Inputs shown in the bottom panel. IgG HC
denotes the heavy chain. (B) Diagram depicting the E1A N-terminus deletion mutants;
dl1101 (∆4-25), dl1102 (∆26-35), dl1103 (∆30-49). (C) HT1080 cells were transfected
with 5 µg of human STING-HA expression vector and 5 µg of N terminus-GFP and Nterminus-GFP deletion mutants dl1101 (∆4-25), dl1102 (∆26-35) and dl1103 (∆30-49).
IgG HC denotes the heavy chain. IgG LC denotes the light chain. Inputs shown in right
panel. Results representative of three independent experiments.
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abolished binding with STING, as compared to WT full length E1A. To verify and explore
further, I co-transfected HEK293 cells with GFP-tagged HAdV-5 13S E1A and a GFPtagged dl1108 E1A construct. The dl1108 E1A mutant construct contains a deletion of
amino acids 122-126, which removes the CXE of the LXCXE motif to effectively abolish
the motif (Figure 3.4A). This mutant has previously been documented to be transformation
defective and does not bind pRb or p130 (Egan et al., 1988; Jelsma et al., 1988).
Immunoprecipitation with anti-STING was followed by western blotting for anti-GFP and
anti-E1A (anti-M73 antibody)(Figure 3.4B). In agreement with Lau and colleagues,
transfection and immunoprecipitation with anti-STING was found to be sufficient for
binding between ectopically expressed STING and endogenous 13S, but contrary to their
findings, the LXCXE mutant dl1108 was still capable of binding STING. There is a slight
spillover in the empty lane because of partial well collapse.
To further my analysis, I chose a different cellular model. HT1080 cells were prepared and
a series of deletion mutants spanning the CR2 region of HAdV-5 (including the LXCXE
motif), were constructed. Deletion mutant dl1107, which deletes amino acids 111-123, and
dl1108, which deletes amino acids 124-127, both disrupt the LXCXE motif. Either of the
two deletion mutants should theoretically inhibit binding with STING if the LXCXE motif
is necessary for the interaction with STING. Additional deletion mutants were constructed
that flanked both sides of the LXCXE motif, or removed part of CR1 (see Figure 3.4A).
Immunoprecipitation with STING was followed by western blotting with anti-GFP. As
shown in figure 3.4C, all of the deletion mutants displayed binding affinity with STING.
There was a noticeable reduction in expression between dl1107 and dl1108 with STING,
which could potentially indicate that the LXCXE motif may play a secondary role in the
interaction with STING.

3.1.5 Analysis of the Conserved Interaction Between STING
and 13S E1A from Representative Members of HAdV Species
A to G
Across the various distinct species and serotypes of Adenovirus, there are multiple
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Figure 3.4. STING binds E1A LXCXE deletion mutants. (A) Diagram depicting
characterized E1A deletion mutants that span CR1, CR2 and the region preceding CR2.
The red box indicates the LXCXE motif. Deletion mutants dl1107 and dl1108 disable
the LXCXE motif. (B) HEK293 cells were transfected with 5 µg of STING-HA and 5
µg of E1A-GFP deletion mutant dl1108. After 24 hr, cell were harvested and lysed,
followed by immunoprecipitation of STING and western blotting for E1A or GFPtagged protein using anti-E1A (anti-M73) and anti-GFP antibodies. 13S E1A at 40kDa
represents endogenous E1A. Inputs shown in the right panel. (C) HT1080 cells were
transfected with 5 µg of human STING-HA expression vector and 5 µg of E1A-GFP
deletion mutants; dl1105, dl1106, dll107, dl1108, and dl1109.After 24 hr, cells were
harvested and lysed, followed by immunoprecipitation of STING and western blotting
for GFP-tagged E1A mutants with anti-GFP antibody. Inputs shown in right panel. IgG
HC denotes the heavy chain. Results representative of two (B) or three independent
experiments (C).
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conserved motifs that interact with important cellular proteins such as GCN5, CtBP, p300
and pRb (Avvakumov et al., 2004; Pelka et al., 2008). The identification of new proteins
that demonstrate conserved interactions with multiple species of E1A may indicate new
important roles for those proteins during the Adenoviral lifecycle. To determine if STING
could bind multiple species of Adenoviral E1A protein, we utilized a series of 13S E1A
constructs representing the major species groups of Adenovirus A through G (Figure 3.5A).
The constructs represented were HAdV-3,-4,-5,-9,-12,-40, and-52. 13S E1A constructs
were co-transfected with STING into HT1080 cells and immunoprecipitation with STING
was followed by western blotting with anti-GFP. The binding between HAdV-52 and
STING was almost non-detectable (Figure 3.5B), but an interaction was detected for all
other serotypes.
The next investigation was to look at the extreme N-terminus of each species as shown in
Figure 3.6A. There is a considerable level of conservation between species within this
region of the N-terminus. Each GFP-tagged E1A mutant construct was co-transfected with
STING into HT1080 cells and immunoprecipitation with STING was followed by western
blotting with anti-GFP. As demonstrated in Figure 3.6B, the N-terminus 1-15AA mutants
of HAdV-5,-3,-9,-12, and -40 interacted with STING, whilst HAdV-52 did not.

3.2 Assessment of the Interaction Between E1A, S6K and
RPS6
Wang and colleagues (2016) demonstrated a novel interaction between mouse p70 S6K1
and mouse STING. The p70 S6 kinase is a mitogen activated serine/threonine kinase
necessary for cell growth and survival. Studies have demonstrated that S6K regulates
protein synthesis (Thomas, 2000), cell cycle progression (Lane et al., 1993), and cell size
(Montagne et al., 1999). Through an in vitro model of chronic activation of the cGASSTING pathway via transduction of cells with recombinant virus, Wang and colleagues
showed that S6K1 associates with the STING-TBK1 IRF3 complex, leading to IRF3
phosphorylation and translocation to the nucleus. Disruption of this S6K1-STING
interaction resulted in the abolition of IRF3 phosphorylation and translocation. I posed the
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Figure 3.5. Interaction between STING and E1A conserved across multiple
species. (A) Diagram depicting the seven (A-G) HAdV species and respective
serotypes. Serotypes highlighted in red were expressed at full length (13S) in GFP
constructs. (B) HT1080 cells were co-transfected with 5 µg of human STING-HA
expression vector and 5 µg of 13S E1A-GFP expression vectors representing the seven
HAdV species; HAdV-3,-4,-5,-9,-12,-40, and -52. After 24 hr, cells were harvested and
lysed, followed by immunoprecipitation of STING and western blotting for GFP-tagged
13S E1A serotypes with anti-GFP antibody. Inputs shown in bottom panel. IgG HC
denotes the heavy chain, IgG LC denotes the light chain. Results representative of three
independent experiments.
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Figure 3.6. E1A extreme N-terminus interaction with STING conservation across
multiple species. (A) Diagram depicting the sequence alignment of amino acids 1-80
across multiple serotypes representing homology across seven HAdV species. Shaded
areas represent conservation in sequence across serotypes. (B) HT1080 cells were
transfected with 5 µg of human STING-HA expression vector and 5 µg of 13S E1AGFP expression vectors representing amino acids 1-14 across seven HAdV species;
HAdV-3,-4,-5,-9,-12,-40, and -52. After 24 hr, cells were harvested and lysed, followed
by immunoprecipitation of STING and western blotting for GFP-tagged E1A serotypes
with anti-GFP antibody. Inputs shown in right panel. IgG HC denotes the heavy chain.
Results representative of three independent experiments.
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question as to whether E1A was involved in this S6K1-STING-TBK1-IRF3 complex. To
date, there has been only one report published investigating induction of p70 S6K by
Adenovirus E1A (de Groot et al, 1995). This study reported that the induction was not
mediated through protein-protein interactions, but this cannot be verified as the relevant
data was not published. I sought to revisit this connection between E1A and S6K, with the
aim of demonstrating that E1A can indeed, bind S6K1. Finding ancillary binding partners
of E1A that also bind STING, TBK1 and IRF3 could further help to investigate the nature
of the E1A-STING interaction. Ancillary binding partners of E1A could bridge the
interaction with STING. In addition to S6K1, there are no existing reports analyzing the
molecular relationship between E1A and ribosomal protein S6 (RPS6). The RPS6 operates
within the mTORC1 signaling pathway to promote protein synthesis and is the most
extensively studied S6K substrate. Nevertheless, the biochemical consequences of RPS6
phosphorylation by S6K have yet to be fully determined (Meyuhas, 2008; Meyuhas &
Dreazen, 2009). Wang and colleagues (2016) did not investigate whether RPS6 was
involved in the S6K1-STING-TBK1-IRF3 complex. Therefore, to extend my exploration
of this topic, I also sought to determine if E1A could interact with RPS6. A novel
interaction between E1A and RPS6 would also facilitate future exploration into how E1A
could potentially modulate known proteins involved in metabolic and innate immune
pathways to create a more conducive environment for viral infection.

3.2.1 Verifying the Interaction Between S6K and STING
To expand on Wang and colleagues (2016) finding that S6K binds STING, I assessed if
this interaction existed in HEK293 cells. I co-transfected a human STING-HA expression
construct with a mouse S6K1-HA expression construct kindly gifted by Wang and
colleagues (McMaster University). Co-immunoprecipitations were undertaken using either
anti-STING or anti-E1A (anti-M73 + anti-M58) antibodies, followed by western blotting
with anti-STING, anti-S6K, and anti-E1A antibodies. As shown in Figure 3.7A,
immunoprecipitation with STING verified that mouse S6K binds to human STING. An
interaction between S6K and STING was observed, and STING also immunoprecipitated
endogenous E1A. The question of whether these three proteins are in complex cannot be
determined from this experiment. Interestingly, immunoprecipitation with E1A
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Figure 3.7. HAdV-5 E1A interacts with mouse S6K1. (A) HEK293 cells were
transfected with 5 µg of human STING-HA expression vector and 5 µg of mouse S6K1HA expression vector. After 24 hr, cells were harvested and lysed, followed by
immunoprecipitation of STING and western blotting for endogenous E1A, S6K1-HA,
and STING-HA. Inputs shown in right panel. IgG HC denotes the heavy chain. (B)
HEK293 cells were transfected with 5 µg of human STING-HA expression vector and
5 µg of mouse S6K1-HA expression vector. After 24 hr, cells were harvested and lysed,
followed by immunoprecipitation of endogenous E1A and western blotting for E1A,
S6K1-HA, and STING-HA. Inputs shown in right panel. IgG HC denotes the heavy
chain. Results representative of two independent experiments.
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(Figure 3.7B) indicated that endogenous E1A was able to co-immunoprecipitate with
exogenous mouse S6K1, and produce a strong signal. On the contrary, endogenous E1A
did not co-immunoprecipitate with exogenous STING. It is to be assumed that E1A and
STING will bind endogenous S6K within the system, but overexpression of mouse S6K1
aids in studying these interactions. When comparing the input signals between STING and
S6K1, the inability of endogenous E1A to bind STING through immunoprecipitation with
E1A was unexpected.

3.2.2 E1A Binds Endogenous S6K and RPS6
The first indications that E1A could potentially bind human S6K and RPS6 came from coimmunoprecipitation studies in HEK293 cells, which endogenously express HAdV-5 E1A.
13S E1A constructs in pcDNA3.1 were co-transfected with STING-HA or pcDNA3.1
vector. As shown in Figure 3.8, immunoprecipitation with E1A (anti-M73), followed by
western blotting for STING-HA, E1A, endogenous S6K, and endogenous RPS6. 13S E1A
alone, was found to co-immunoprecipitate with both endogenous S6K and RPS6. The p70
S6K signal was very strong, while the p85 S6K signal was much weaker. The presence of
STING did not appear to be a requirement for co-immunoprecipitation of S6K and RPS6
with 13S HAdV-5 E1A. In support of previous results (Figure 3.7), the endogenous E1A
present in the control did not co-immunoprecipitate well with STING-HA. In addition,
overexpression of 13S E1A was required to co-immunoprecipitate E1A with RPS6.
However, a strong p70 S6K signal was detected with E1A in the control coimmunoprecipitation, but not p85 S6K. If E1A does not require STING to bind S6K, then
S6K may act as a bridge between E1A and STING.

3.2.3 Characterizing the Interaction Between Mouse S6K1
and HAdV E1A
To verify the interaction of HAdV with mouse S6K1, we overexpressed these proteins with
epitope tags in HT1080 cells for co-immunoprecipitation studies. We used mouse S6K1
because it was kindly gifted by Wang and colleagues and has 99% sequence homology to
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Figure 3.8. HAdV-5 E1A binds endogenous human S6K and RPS6. HEK293 cells
were transfected with 5 µg of human STING-HA expression vector and 5 µg of 13S
E1A-pcDNA3.1 expression vector (no tag). After 24 hr, cells were harvested and lysed,
followed by immunoprecipitation of STING and western blotting for endogenous E1A,
endogenous S6K, and endogenous RPS6. Inputs shown in right panel. Results
representative of two independent experiments.
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Figure 3.9. HAdV-5 interaction with mouse S6K1 conserved across serotypes.
HT1080 cells were transfected with 5 µg of HAdV 13S-GFP expression vectors
representing HAdV-3,-4,-5,-9,-40-and -52, and 5 µg of mouse S6K1-HA expression
vector. After 24 hr, cells were harvested and lysed, followed by immunoprecipitation
of S6K and western blotting for E1A-GFP. Inputs shown in right panel. IgG HC denotes
the heavy chain. Results representative of three independent experiments.
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human S6K1. To assess the conservation of this reaction, GFP-tagged 13S E1A serotypes
representing the major Adenoviral families were co-immunoprecipitated with HA-tagged
S6K1 using anti-S6K1 antibody. As shown in Figure 3.9, western blotting was undertaken
with anti-GFP antibody and the results indicate that HAdV-5,-3,-4,-9, and -12, have
relatively strong interactions with mouse S6K1, as compared to HAdV-40 and -52. This
indicates that the interacting motif is fairly well conserved but not present within all E1A
species.

3.2.4 Assessing the Effect of Ectopically Expressed S6K2 on
HAdV-5 E1A-S6K1 and HAdV-5 E1A-RPS6 Interaction
The physiological and cellular roles of S6K1 are well documented (Magnuson et al., 2012),
but less is known about S6K2. Over the past few years, researchers have demonstrated that
S6K1 and S6K2 have high sequence homology, but S6K2 has additional cellular functions
that are independent of S6K1 (Pardo & Seckl, 2013). The predominant form of S6K1, p70,
is localized mainly to the cytoplasm, while the p85 isoform, which contains a nuclear
localization sequence, is mainly found within the nucleus. S6K2 has two isoforms, a
predominant p54 form and a p56 form. Both of these S6K2 isoforms contain nuclear
localization signals and reside mainly in the nucleus of resting cells (Karlsson et al., 2015).
Within human tissues, S6K2 is expressed at various levels, but expression levels are often
inversely correlated with those of S6K1 (Nardella et al., 2011). I wanted to determine if
overexpressing S6K2 protein in HT1080 cells effected protein expression levels of S6K1.
I also wished to determine if overexpression of RPS6 effected the interaction between
RPS6 and 13S E1A, and S6K1 and 13S E1A.
A human S6K2 plasmid, and a human RPS6 plasmid, were constructed for co-transfection
into HT1080 cells with 13S E1A. As shown in Figure 3.10, immunoprecipitation with E1A
(anti-M73 antibody), was followed by western blotting with anti-S6K antibody and antiRPS6 antibody. The results suggest that S6K can bind RPS6 and co-immunoprecipitate
with E1A. The limitation to this particular experiment was that the anti-S6K antibody used
is specific for p70 and p85 S6K1, and not S6K2. Our previous results demonstrated that
endogenous E1A in HEK293 cells could immunoprecipitate with endogenous p70 S6K1
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Figure 3.10. Overexpression of RPS6 and S6K2 are required for interaction
between ectopically expressed HAdV-5 E1A and p70 S6K. HT1080 cells were
transfected with 5 µg of HAdV-5 13S (no tag) expression vector and 5 µg of human
S6K2 expression vector or 5 µg of human RPS6 expression vector. After 24 hr, cells
were harvested and lysed, followed by immunoprecipitation of E1A and western
blotting for S6K1 and RPS6. Inputs shown in right panel. IgG HC denotes the heavy
chain. Results representative of two independent experiments.
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(Figure 3.8). However, in our HT1080 cellular model, transfected 13S E1A construct did
not immunoprecipitate with endogenous p70 or p85 S6K1. On the contrary, co-transfection
of either S6K2 or RPS6 with 13S E1A did result in the co-immunoprecipitation of p70/p85
S6K1 with E1A. The overexpression of S6K2 and RPS6 would appear to enhance
expression of S6K1.

3.2.5 Assessing the Conserved Nature of the E1A and RPS6
Interaction
Since the novel interaction between RPS6 and HAdV-5 E1A was established in my earlier
studies, I sought to evaluate if this interaction was conserved across multiple species of
adenovirus. Immunoprecipitation experiments with RPS6, were followed by western
blotting for GFP and RPS6. The adenovirus E1A species constructs were 13S GFP-tagged
isoforms. As shown in Figure 3.11, HAdV-5 E1A was the only E1A species found to
interact with RPS6. This verifies earlier E1A-RPS6 interaction experiments that used only
the 13S HAdV-5 E1A isoform (Figure 3.10). This result indicates that HAdV-5 E1A is
unique in its binding to RPS6, and that the E1A-RPS6 interaction is not conserved across
all species of Adenovirus, potentially indicating that the interaction is not mediated through
conserved linear motifs.
Ribosomal proteins are not exclusively cytoplasmic, for example the the RPS6 protein has
the ability to shuttle across the nuclear membrane and accumulate in the nucleus. To test
whether RPS6 binds HAdV-5 in the presence of STING, and therefore potentially in the
cytoplasm, we co- transfected 13S E1A-pcDNA, dl1106-pcDNA, and dl1108-pcDNA, with
STING-HA into HT1080 cells. Immunoprecipitation with endogenous RPS6 was followed
by western blotting for E1A and STING-HA (Figure 3.12). If endogenous RPS6 was able
to bind overexpressed STING, then we expected to see a positive signal, but this was not
observed. Endogenous RPS6 did however, bind overexpressed 13S E1A and dl1108
deletion mutant, but there was no strong signal observed with dl1106 or dl1107 deletion
mutants. The deletion mutant dl1107 and particularly dl1106 abolish stretches of amino
acid residues that are not conserved across all HAdV species and are unique to HAdV-5,
whereas the dl1108 deletion mutant abolishes a conserved amino acid region.
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Figure 3.11. E1A interaction with RPS6 is unique for HAdV-5 serotype. HT1080
cells were transfected with 5 µg of HAdV 13S-GFP expression vectors representing
HAdV-3,-4,-5,-9,-40-and -52, and 5 µg of RPS6 expression vector. After 24 hr, cells
were harvested and lysed, followed by immunoprecipitation of RPS6 and western
blotting for E1A-GFP. Inputs shown in right panel. IgG HC denotes the heavy chain.
Results representative of two independent experiments.
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Figure 3.12. HAdV-5 E1A deletion mutants adjacent to or located at the Nterminus of CR2 abolish binding with RPS6. HT0180 cells were transfected with 5
µg of HAdV-5 13S or deletion mutant expression vectors dl1106, dl1007, and dl1108
(no tag), and 5 µg of STING-HA expression vector. After 24 hr, cells were harvested
and lysed, followed by immunoprecipitation of RPS6 and western blotting for E1A
(anti-M73) and STING-HA. Inputs shown in right panel. Results representative of two
independent experiments.
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Chapter 4
Discussion
4.1

Mapping the interaction between E1A and STING

The ability to evade type I IFN responses is a fundamental aspect of the viral lifecycle.
Viruses employ numerous strategies to conceal their presence and disable cellular innate
defences. As discussed in the introduction, previous studies have described how human
Adenovirus can modulate secondary type I IFN responses, but evasion of the primary type
I IFN response is less well understood. The group of Stetson (Lau et al., 2015) discovered
that HAdV-5 E1A could antagonize the cGAS-STING pathway in HEK293 cells, but the
nature of the protein-protein interaction between HAdV-5 E1A and STING required further
investigation.
This study was based on the indication from the group of Stetson that HAdV-5 E1A
interacts with STING through the LXCXE motif, and that this antagonism would
theoretically prevent the phosphorylation of IRF3 and TBK1, subsequently disabling the
release of type I IFN. The involvement of the zinc finger located in CR3 was also
postulated, though without validation with data, as potentially being involved in the E1ASTING interaction (Lau et al., 2015). These studies established parameters from which my
own experiments initiated.
My data, derived here from co-immunoprecipitation studies, does not support the concept
that the LXCXE motif is both necessary and sufficient for binding to STING. As described
in section 1.4, the cGAS-STING DNA sensing pathway has several distinct components,
but many of these are in complex with each other. Previous studies have demonstrated that
cGAS is not expressed in HEK293 cells, therefore, STING is assumed to be the DNA
sensor in that pathway. The latest communication from the group of Stetson indicated that
the early events of this pathway were intact, suggesting that STING traffics from the
endoplasmic reticulum and recruits TBK1. Phosphorylation of IRF3 on serine 386 was

74
intact, while phosphorylation of serine 396 was impaired (Burleigh & Stetson, 2016). This
suggests that E1A was targeting a later step in the pathway and binds STING in complex
with other proteins. Indeed, the E1A-STING interaction may not be a direct protein-protein
interaction. Wang et al. (2016) found that co-transfection of a plasmid encoding STING
together with a plasmid encoding S6K1 augmented the STING-dependent phosphorylation
of serine 396 of endogenous IRF3 in HEK293T cells. I demonstrated that HAdV-5 E1A
binds STING, but we cannot rule out the possibility that HAdV-5 E1A binds STING
through S6K1, or binds a surface created by the complex of these two proteins.
I began this study with the expectation that STING would bind HAdV-5 E1A through the
LXCXE motif, much in the same way that E1A binds pRb through the LXCXE motif.
Previous members of the laboratory have shown that an E1A CR2 deletion mutant, which
encodes the LXCXE sequence, can readily co-immunoprecipitate with pRb following cotransfection experiments (unpublished data). I expected to observe a strong interaction
between STING and CR2 using co-immunoprecipitation experiments, but this was not
seen. Through my own studies, I also could not confirm Stetson’s finding that an LXCXE
mutant abolished E1A binding with STING in HEK293 cells. When I expanded across an
atlas of mutations spanning the CR2 region and conducted my experiments in HT1080
cells, I observed binding between STING and E1A was only slightly diminished. These
results indicated that other regions of E1A were likely involved in mediating the interaction
with STING.
The N-terminal region of E1A, covering amino acid residues 1-82, consistently bound to
STING despite lower overall expression levels in the input cell lysate. Further analysis of
the N-terminus led me to construct expression plasmids containing various portions of the
E1A N-terminal sequence. Co-immunoprecipitation experiments demonstrated that the
first fourteen residues of HAdV-5 E1A were mediating an interaction with STING.
The conserved regions of E1A are largely considered to be disordered, predicted using the
online tool PONDR (predictor of natural disordered regions)(Pelka et al., 2013). E1A is
well characterized for its ability to interact with proteins through short linear interaction

75
motifs (Pelka et al., 2013). Linear motifs are also regarded as ‘evolutionary switches’
because subtle amino acid changes can cause short sequences in linear motifs to appear
and disappear (Neduva & Russell, 2005). The short lengths of these motifs typically mean
that the interactions they mediate are transient and of low affinity. In order to verify that
the interaction between STING and the first 14 amino acid residues of E1A are not a
laboratory artifact of protein fragmentation, deletion mutants were prepared within the Nterminus that eliminated these amino acid residues. This approach complements earlier
experiments because the deletion mutants would not bind STING if the 14 amino acid
residues were critical for the interaction. The binding between STING and the E1A Nterminus was greatly diminished in E1A deletion mutants lacking amino acids residues 4
to 25. Thus, the N-terminus of E1A appears necessary and sufficient for mediating the
interaction with STING.
Determining the conservation of the interaction between STING and 13S E1A could
provide insight into the importance of the interaction from an evolutionary perspective. I
demonstrated that the interaction between E1A and STING was fairly conserved across
most species of E1A representing the major families of Adenovirus. The conservation of
interaction also indicated that conserved motifs within these species may be facilitating the
E1A and STING interaction. To further investigate the N-terminal region, I prepared Nterminal constructs spanning the first 15 amino acid residues of various E1A species. I
observed that the N-terminus (1-15AA) of HAdV-3,-9,-12, and -40 interacted with STING,
while HAdV-52 and 13S ∆N-terminus (∆1-80) did not. This suggests that the N-terminus
(1-15AA) interaction with STING is likely significant and fundamental across most
Adenoviral species for type I IFN evasion strategies. HAdV-52, which did not bind STING,
contains considerable differences in the amino acid residues of the extreme N-terminus as
compared to other Adenoviral species. Indeed, HAdV-52 is the most divergent species
(refer to Figure 1.5). Interestingly, an interaction was detected between STING and the
HAdV-9 N-terminus. Beyond the first 8 amino acids, the HAdV-9 N-terminus is divergent
from the other representative serotypes, which would indicate that further exploration of
the extreme N-terminus, namely amino acids 1-8, should continue.
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Past studies have demonstrated that the E1A N-terminus can interact with multiple proteins
including the TATA binding domain (TBP), p300 and CREB-binding domain (CBP)
(Boyd et al., 2002). Mutation of cysteine at position 6 to alanine abolished the E1A
interaction with TBP, p300 and CBP. Following infection, the phosphorylation of IRF3
results in the dimerization and translocation to the nucleus. Upon accumulating in the
nucleus, IRF3 binds with CBP and p300. The binding of E1A to p300/CBP through the Nterminus prevents this interaction between IRF3 and CBP/p300, resulting in an inhibition
of type I IFN production (Wathelet et al., 1998; Yang et al., 2002, 2004; Yoneyama et al.,
1998). Despite reports that p300 can be found in the cytoplasm, the prevailing notion is
that the nuclear expression of p300 is predominant (Rotte et al., 2013). This suggests there
is a novel binding region within the N-terminus that either binds STING within the
cytoplasm, or a protein in complex with STING. As STING is not known to accumulate in
the nucleus, future work should remain focused on the discovery of E1A cytoplasmic
binding partners.

4.2

Characterizing the interaction between E1A, S6K1 and

RPS6
Wang and colleagues (2016) revealed that S6K1 played a new role in the induction of type
I IFN responses. Our second aim of this study was to determine whether E1A was involved
in the STING-S6K1 interaction, and whether the ribosomal protein S6, which is
downstream of S6K1, could also be potentially involved.
A study by de Groot et al. (1995) reported that the HAdV-5 N-terminus (possibly including
CR1) was responsible for enhancing expression of p70 S6K. However, they stated (without
supporting data) that there was no protein-protein interaction. I revisited this question and
showed that E1A can bind both endogenous and exogenous mouse and human p70 S6K
through co-immunoprecipitation studies. I used a mouse S6K1 construct because it was
donated by Wang and colleagues (McMaster University) and has 99% amino acid sequence
homology to human S6K1. I made the novel finding that binding of 13S E1A to p70 S6K1
is fairly conserved across multiple E1A species. I also extended the study of Wang et al.
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(2016) by demonstrating that human STING could immunoprecipitate with mouse p70
S6K1. The precise binding configuration between p70 S6K1, E1A and STING has yet to
be determined, and should be a priority for future investigation. Since E1A binds p70 S6K1
in the absence of STING, it could be postulated that E1A binds p70 S6K1 through a
conserved region, and p70 S6K in turn, binds STING. However, we cannot dismiss the
possibility that these are separate events and E1A binds p70 S6K1 irrespective of any type
I IFN evasion strategies.
Changes in protein expression level of p85 S6K in response to E1A is unclear and further
studies should be conducted to determine if E1A may somehow discriminate between the
p70 S6K isoform and the p85 S6K isoform. The p85 S6K isoform is less abundant than
p70 S6K in most cell types (Reinhard et al., 1992), which explains why we observe stronger
interactions between E1A and p70 S6K. The p70 S6K isoform was observed to
immunoprecipitate with endogenous E1A in HEK293 cells, whereas the p85 isoform did
not. Overexpression of the E1A protein is required to immunoprecipitate p85 S6K1 with
E1A. However, like p70 S6K, p85 S6K does not require the presence of STING to bind
E1A.
Understanding the biological functions of S6K2 has been largely neglected compared to
the number of studies investigating S6K1. In addition, the changes in S6K2 expression
upon viral infection is largely undetermined. It would be interesting to determine if HAdV
E1A interacts with S6K2, and if HAdV infection alters the protein expression of S6K2.
Indications that E1A could bind RPS6 initially came from positive endogenous RPS6
signals found in co-immunoprecipitation experiments transfecting 13S E1A into HEK293
cells. When I co-transfected RPS6 with multiple HAdV species in HT1080 cells, I initially
encountered problems in detecting a signal. However, by increasing the expression of the
exogenous RPS6 protein I was able to determine that RPS6 binds HAdV-5, but not the
other E1A species. The result demonstrating that dl1106 failed to bind RPS6 may suggest
that E1A HAdV-5 has a unique binding region. The absence of RPS6 binding to STING
could be due to the fact that STING resides in the cytoplasm, while RPS6 can be found in
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the nucleus. E1A primarily localizes to the nucleus (Jiang et al., 2006) and this may be the
site of interaction with RPS6, however, E1A may also redistribute RPS6 proteins
intracellularly.

4.3

Significance of Findings and Future Directions

My studies have shown that amino acid residues 1-14 of the E1A N-terminus are
responsible for mediating the interaction between E1A and STING, and that this interaction
is quite conserved across Adenoviral species. This demonstrates a novel binding site within
the N-terminus region of E1A, distinct from the putative interaction via the LXCXE motif
in CR2. We have also discovered novel E1A binding partners; p70 S6K1, p85 S6K1, and
RPS6. The interaction between E1A and S6K1 is fairly conserved, indicating that a
conserved motif is likely involved in mediating this interaction, either independently or in
conjunction with additional binding sites. The novel interaction between HAdV-5 E1A and
RPS6 is not conserved across adenoviral species and does not involve the STING complex.
To verify the RPS6-E1A interaction, other serotypes of Adenovirus species C should also
be tested for their ability to bind RPS6. Determining the functional significance of this
interaction would expand our knowledge of E1A’s ability to modulate proteins involved in
metabolic pathways. This study provides the first indication that E1A can target a
downstream component of the mTOR pathway. The functional significance of the E1AS6K1 interaction also needs to be fully elucidated. E1A may modulate S6K for several
purposes, and may act as both an enhancer and repressor of activity. Enhancing the role of
S6K in protein synthesis could provide an environment more conducive to viral replication,
whereas repressing an S6K-STING interaction blocks the type I IFN response.
A catalogue of point mutations within the N-terminus region of E1A needs to be
constructed to further identify the residues critical for interaction with STING. The region
of S6K1 binding on E1A also needs to be mapped, providing specific reagents for future
studies that will identify the exact impact of this interaction on the virus replicative cycle.
To determine if E1A binds STING through S6K1 or co-binds both proteins, gene
knockdown studies could be undertaken whereby E1A and STING are co-transfected into
S6K1-/- cells followed by co-immunoprecipitation for STING. As S6K1 was shown by
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Wang et al. (2016) to augment the STING-dependent phosphorylation of IRF3,
theoretically, S6K1 would be an ideal target for E1A to disable the type I IFN response.
Further investigation is required to verify the location of the E1A-S6K1 interaction, and
the E1A-RPS6 interaction. Immunohistochemical staining of endogenous E1A in HEK293
cells, or transfection of epitope-tagged constructs of E1A, S6K1, STING and RPS6 into
HT1080 cells followed by immunofluorescence to track their localization within the cell
could be utilized. The ability of E1A to relocalize components of the STING pathway
should also be examined.
To complement our previous results, a primary cell line such as mouse embryonic
fibroblasts could be transduced with retroviruses encoding mutant E1A with mutations that
disrupt binding with S6K. Changes in IFN-β mRNA levels upon stimulation with foreign
dsDNA could be evaluated with qPCR. If disruption of binding between E1A and S6K
results in rescue of the type I IFN response, then an increase in IFN-β mRNA should be
observed. In addition, a screen could be developed in STING and cGAS knockdown cells
to verify regions of E1A that block IFN-β. Co-transfection of STING, cGAS, and mutant
E1A expression plasmids, together with an IFN-β promoter luciferase reporter construct
can identify which mutations rescue IFN-β activation (Ma et al., 2015). To complement
our study with an infection model, viruses with deletion mutants in E1A rendering them
unable to antagonize the STING-pathway should be constructed and tested in primary cell
lines or the HEK293 cell line treated with CRISPR targeting deletion of the E1A loci.
Lau et al. identified the Human Papilloma Virus (HPV) E7 protein as an antagonist of the
STING pathway because it has an LXCXE motif. However, the HPV E7 protein does not
have sequence homology to the HAdV N-terminus region discovered to interact with
STING. Therefore, it would be of interest to determine if the E7 LXCXE motif, or a motif
that overlaps the LXCXE motif may be inhibiting the phosphorylation of IRF3 at serine
396. I suggest this because the LXCXE motif HPV E7 protein was found to be involved
in binding the carboxyl-terminal transactivation domain of IRF1 (Park et al., 2000).
Additionally, a PEST domain that overlaps the LXCXE motif in the HPV 16 E7 protein
has been found to interact with IRF9 (Antonsson et al., 2006). I would test to see if the
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E1A LXCXE motif was involved in abolishing the phosphorylation of IRF3 at serine 396.
E1A could be binding STING or S6K1 through the N-terminus and the LXCXE motif may
be blocking IRF3 phosphorylation.
I wish to point out the drawbacks of the HEK293 cell model with respect to experiments
analyzing the STING-pathway. Many studies analyzing innate immune signaling have
been completed in HEK293 cells. In addition to the absence of cGAS, a study published in
August 2017 by Wu et al. revealed that STING does not undergo the same degradation
processes in HEK293 cells as it does in human diploid cells. These processes are vital
regulatory mechanisms used to avoid an excessive innate immune response. In human
diploid cells, they reported that after stimulation by dsDNA, RIG-1 was found downstream
of STING and operated with IL-6 and ULK1 through a negative feedback loop to activate
and control STING degradation. Low levels of RIG-1 and IL-6 in HEK293 cells were
found to be insufficient for ULK1 activation, resulting in the loss of STING degradation
mechanisms (Wu et al., 2017). This leads to the question of whether HEK293 cells are a
reliable model to study innate immune responses. HEK293 cells are generated through the
transformation of normal HEK cells with sheared HAdV-5 E1A DNA. HEK293 cells have
significantly less number of chromosomes than normal human diploid cells and are capable
of infinite expansion. It was historically known that stimulation by dsDNA did not produce
a type I IFN response in HEK293 cells (Lau et al., 2015). If E1A in HEK293 cells
permanently antagonizes the STING-S6K1-TBK1-IRF3 complex, then through the process
of passaging, HEK293 cells may no longer require the need for STING regulation. HeLa
cells should also be investigated for presence of STING degradation pathways. In addition,
future studies investigating viral modulation of metabolic pathways should be cautious
about the enhanced expression levels of S6K in HEK293 cells, especially if S6K is used as
a marker for protein synthesis.
The present study has added new understanding to the intracellular interactors of E1A, and
opened new avenues of research. Substantial studies remain to confirm the functional role
of the protein-protein interactions identified.
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